11.06.2014 Views

Reference List Lupus Nephritis Update Search Feb 1, 2012 to Dec ...

Reference List Lupus Nephritis Update Search Feb 1, 2012 to Dec ...

Reference List Lupus Nephritis Update Search Feb 1, 2012 to Dec ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Reference</strong> <strong>List</strong><br />

<strong>Lupus</strong> <strong>Nephritis</strong> <strong>Update</strong> <strong>Search</strong><br />

<strong>Feb</strong> 1, <strong>2012</strong> <strong>to</strong> <strong>Dec</strong> 31, <strong>2012</strong><br />

From end of original search <strong>to</strong> end of 4th quarter <strong>2012</strong><br />

This update search is the result of the replicated search strategy used <strong>to</strong> identify studies for the<br />

original evidence report that informed guideline development for Screening, Treatment, and<br />

Management of <strong>Lupus</strong> <strong>Nephritis</strong>.<br />

These results have not been screened <strong>to</strong> determine relevancy of studies. There may be some<br />

overlap with the results of the original search, and some references outside the indicated time<br />

frame. There may be other sources not seached that would yield relevant studies.<br />

1. Watson L, Beresford MW. Urine biomarkers in juvenile-onset SLE nephritis. Pediatr Nephrol<br />

2013;28:363-74. PMID: 22588674<br />

2. Arazi A, Neumann AU. The role of positive feedback loops involving anti-dsDNA and antianti-dsDNA<br />

antibodies in au<strong>to</strong>immune glomerulonephritis. J Theor Biol 2013;319:8-22. PMID:<br />

23142592<br />

3. Rocha LP, Carminati CR, Machado JR, Laterza VL, dos Reis MA, Correa RR. Prevalence of<br />

nephropathies in children and adolescents and alterations in renal biopsies in Minas Gerais,<br />

Brazil, from 1996 <strong>to</strong> 2010. Ann Diagn Pathol 2013;17:22-7. PMID: 22658343<br />

4. Alunno A, Bis<strong>to</strong>ni O, Bar<strong>to</strong>loni E, Caterbi S, Bigerna B, Tabarrini A ,et al. IL-17-producing<br />

CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are<br />

resistant <strong>to</strong> corticosteroids in patients with primary Sjogren's syndrome. Ann Rheum Dis<br />

2013;72:286-92. PMID: 22904262<br />

5. Hulst M, Loeffen W, Weesendorp E. Pathway analysis in blood cells of pigs infected with<br />

classical swine fever virus: comparison of pigs that develop a chronic form of infection or<br />

recover. Arch Virol 2013;158:325-39. PMID: 23053521<br />

6. Yang ML, Gee AJ, Gee RJ, Zurita-Lopez CI, Khare S, Clarke SG ,et al. <strong>Lupus</strong> au<strong>to</strong>immunity<br />

altered by cellular methylation metabolism. Au<strong>to</strong>immunity 2013;46:21-31. PMID: 23039363<br />

7. Goh YP, Naidoo P, Ngian GS. Imaging of systemic lupus erythema<strong>to</strong>sus. Part II:<br />

Gastrointestinal, renal, and musculoskeletal manifestations. Clin Radiol 2013;68:192-202.<br />

PMID: 22901453<br />

8. Goh YP, Naidoo P, Ngian GS. Imaging of systemic lupus erythema<strong>to</strong>sus. Part I: CNS,<br />

cardiovascular, and thoracic manifestations. Clin Radiol 2013;68:181-91. PMID: 22901452


9. Mos<strong>to</strong>wska A, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP. Vitamin D recep<strong>to</strong>r<br />

gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythema<strong>to</strong>sus.<br />

Mol Biol Rep 2013;40:803-10. PMID: 23065277<br />

10. Canpolat N, Kasapcopur O, Caliskan S, Gokalp S, Bor M, Tasdemir M ,et al. Ambula<strong>to</strong>ry<br />

blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic<br />

lupus erythema<strong>to</strong>sus. Pediatr Nephrol 2013;28:305-13. PMID: 23052654<br />

11. Telles RW, Lanna CC, Souza FL, Rodrigues LA, Reis RC, Ribeiro AL. Causes and<br />

predic<strong>to</strong>rs of death in Brazilian lupus patients. Rheuma<strong>to</strong>l Int 2013;33:467-73. PMID: 22461184<br />

12. Gao J, Chevalier J, Auh YH, Rubin JM, Wang H, Sun LN ,et al. Correlation between<br />

Doppler parameters and renal cortical fibrosis in lupus nephritis: a preliminary observation.<br />

Ultrasound Med Biol 2013;39:275-82. PMID: 23245821<br />

13. Java A, Atkinson J, Salmon J. Defective complement inhibi<strong>to</strong>ry function predisposes <strong>to</strong> renal<br />

disease. Annu Rev Med 2013;64:307-24. PMID: 23121180<br />

14. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from<br />

clinical trials. AAPS J 2013;15:195-218. PMID: 23143785<br />

15. Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF ,et al. Induction<br />

and Maintenance Treatment of Proliferative <strong>Lupus</strong> <strong>Nephritis</strong>: A Meta-analysis of Randomized<br />

Controlled Trials. Am J Kidney Dis 2013;61:74-87. PMID: 23182601<br />

16. Chao CT, Wang WJ, Ting JT. Wunderlich syndrome from lupus-associated vasculitis. Am J<br />

Kidney Dis 2013;61:167-70. PMID: 22981757<br />

17. Lee AC, Al-Saad KK. Successful hema<strong>to</strong>poietic cell transplantation in a child with sickle cell<br />

disease and systemic lupus erythema<strong>to</strong>sus. Bone Marrow Transplant 2013;48:151-2. PMID:<br />

22659682<br />

18. Hara A, Furuichi K, Higuchi M, Iwata Y, Sakai N, Kaneko S ,et al. Au<strong>to</strong>antibodies <strong>to</strong><br />

erythropoietin recep<strong>to</strong>r in patients with immune-mediated diseases: relationship <strong>to</strong> anaemia with<br />

erythroid hypoplasia. Br J Haema<strong>to</strong>l 2013;160:244-50. PMID: 23151030<br />

19. Kopsachilis N, Tsaousis KT, Tourtas T, Tsinopoulos IT. Severe chronic blepharitis and<br />

scarring ectropion associated with discoid lupus erythema<strong>to</strong>sus. Clin Exp Op<strong>to</strong>m 2013;96:124-5.<br />

PMID: 22845188<br />

20. Giannico G, Fogo AB. <strong>Lupus</strong> nephritis: is the kidney biopsy currently necessary in the<br />

management of lupus nephritis? Clin J Am Soc Nephrol 2013;8:138-45. PMID: 22977215<br />

21. Rovin BH, Parikh SV, Hebert LA, Chan TM, Mok CC, Ginzler EM ,et al. <strong>Lupus</strong> <strong>Nephritis</strong>:<br />

Induction Therapy in Severe <strong>Lupus</strong> <strong>Nephritis</strong>--Should MMF Be Considered the Drug of Choice?<br />

Clin J Am Soc Nephrol 2013;8:147-53. PMID: 22879439


22. Kim HA, Nam JY, Jeon JY, An JM, Jung JY, Bae CB ,et al. Serum Growth Arrest-Specific<br />

Protein 6 Levels are a Reliable Biomarker of Disease Activity in Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus.<br />

J Clin Immunol 2013;33:143-50. PMID: 22914895<br />

23. Berthelot JM, Jamin C, Amrouche K, Le GB, Maugars Y, Youinou P. Regula<strong>to</strong>ry B cells<br />

play a key role in immune system balance. Joint Bone Spine 2013;80:18-22. PMID: 22858147<br />

24. Doherty T, Austin S, Newell B, Kiely P. Mycophenolate mofetil-induced erythroid<br />

hypoplasia in a patient with systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> 2013;22:213-5. PMID:<br />

23257406<br />

25. Yen TH, Yang HY, Yeh YH, Chu PH, Wen CJ, Fu JF ,et al. Aliskiren attenuates proteinuria<br />

in mice with lupus nephritis by a blood pressure-independent mechanism. <strong>Lupus</strong> 2013;22:180-9.<br />

PMID: 23257405<br />

26. Daleboudt G, Reinders M, Hartigh J, Huizinga T, Rabelink A, de FJ ,et al. Concentrationcontrolled<br />

treatment of lupus nephritis with mycophenolate mofetil. <strong>Lupus</strong> 2013;22:171-9.<br />

PMID: 23257398<br />

27. Becker-Merok A, Ostli-Eilersten G, Lester S, Nossent J. Circulating interferon-alpha2 levels<br />

are increased in the majority of patients with systemic lupus erythema<strong>to</strong>sus and are associated<br />

with disease activity and multiple cy<strong>to</strong>kine activation. <strong>Lupus</strong> 2013;22:155-63. PMID: 23213068<br />

28. Sharma A, Shamanna S, Kumar S, Wanchu A, Bambery P, Singh S ,et al. Causes of<br />

mortality among inpatients with systemic lupus erythema<strong>to</strong>sus in a tertiary care hospital in North<br />

India over a 10-year period. <strong>Lupus</strong> 2013;22:216-22. PMID: 23192325<br />

29. Teh C, Ling G. Causes and predic<strong>to</strong>rs of mortality in hospitalized lupus patient in Sarawak<br />

General Hospital, Malaysia. <strong>Lupus</strong> 2013;22:106-11. PMID: 23112253<br />

30. Onishi A, Sugiyama D, Tsuji G, Nakazawa T, Kogata Y, Tsuda K ,et al. Mycophenolate<br />

mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus<br />

nephritis in a Japanese population: a retrospective study. Mod Rheuma<strong>to</strong>l 2013;23:89-96. PMID:<br />

22447557<br />

31. Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B ,et al. LG3 fragment of<br />

endorepellin is a possible biomarker of severity in IgA nephropathy. Proteomics 2013;13:142-52.<br />

PMID: 23161552<br />

32. Shimohata H, Higuchi T, Ogawa Y, Fujita S, Nagai M, Imaizumi M ,et al. Human parvovirus<br />

b19-induced acute glomerulonephritis: a case report. Ren Fail 2013;35:159-62. PMID: 23113616<br />

33. Chang YS, Liu CJ, Wu TH, Chaou CH, Lin KC, Ou SM ,et al. Survival analysis in systemic<br />

lupus erythema<strong>to</strong>sus patients on maintenance dialysis: a nationwide population-based study in<br />

Taiwan. Rheuma<strong>to</strong>logy (Oxford) 2013;52:166-72. PMID: 23204553


34. Wu T, Mohan C. <strong>Lupus</strong> nephritis - alarmins may sound the alarm? Arthritis Res Ther<br />

<strong>2012</strong>;14:129. PMID: 23270666<br />

35. Cabrejas LA, Orden RC, Garcia Iniguez JP, Madurga RP, Janer SE, Justa Roldan ML.<br />

[Pulmonary thromboembolism in a child with lupus nephropathy.]. An Pediatr (Barc) <strong>2012</strong>;<br />

PMID: 23280238<br />

36. Shao X, Yang R, Yan M, Li Y, Du Y, Raman I ,et al. Inducible expression of kallikrein in<br />

renal tubular cells protect mice from spontaneous lupus nephritis. Arthritis Rheum <strong>2012</strong>; PMID:<br />

23280471<br />

37. Onder FO, Yurekli OT, Oztas E, Kalkan IH, Koksal AS, Akdogan M ,et al. Features of<br />

systemic lupus erythema<strong>to</strong>sus in patients with au<strong>to</strong>immune hepatitis. Rheuma<strong>to</strong>l Int <strong>2012</strong>;<br />

PMID: 23269566<br />

38. Fismen S, Thiyagarajan D, Seredkina N, Nielsen H, Jacobsen S, Elung-Jensen T ,et al.<br />

Impact of the Tumor Necrosis Fac<strong>to</strong>r Recep<strong>to</strong>r-Associated Protein 1 (Trap1) on Renal DNaseI<br />

Shutdown and on Progression of Murine and Human <strong>Lupus</strong> <strong>Nephritis</strong>. Am J Pathol <strong>2012</strong>; PMID:<br />

23273922<br />

39. Connelly K, Morand EF, Hoi AY. Asian ethnicity in systemic lupus erythema<strong>to</strong>sus: an<br />

Australian perspective. Intern Med J <strong>2012</strong>; PMID: 23279565<br />

40. Badot V, Luijten RK, van Roon JA, Depresseux G, Aydin S, Van den Eynde BJ ,et al. Serum<br />

soluble interleukin 7 recep<strong>to</strong>r is strongly associated with lupus nephritis in patients with systemic<br />

lupus erythema<strong>to</strong>sus. Ann Rheum Dis <strong>2012</strong>; PMID: 23264357<br />

41. Jayabose S, Nowicki TS, Dunbar J, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.<br />

Acquired Thrombotic Thrombocy<strong>to</strong>penic Purpura in Children: A Single Institution Experience.<br />

Indian J Pediatr <strong>2012</strong>; PMID: 23263974<br />

42. Salazar KD, Copeland CB, Wood CE, Schmid JE, Luebke RW. Evaluation of anti-nuclear<br />

antibodies and kidney pathology in Lewis rats following exposure <strong>to</strong> Libby amphibole asbes<strong>to</strong>s.<br />

J Immuno<strong>to</strong>xicol <strong>2012</strong>; PMID: 23256773<br />

43. Zhen J, Ling-Yun S, Yao-Hong Z, Xiang-Dang W, Jie-Ping P, Miao-Jia Z ,et al. Deathrelated<br />

fac<strong>to</strong>rs of systemic lupus erythema<strong>to</strong>sus patients associated with the course of disease in<br />

Chinese populations: multicenter and retrospective study of 1,958 inpatients. Rheuma<strong>to</strong>l Int<br />

<strong>2012</strong>; PMID: 23263494<br />

44. Alchi B, Jayne D, Labopin M, Ko<strong>to</strong>va O, Sergeevicheva V, Alexander T ,et al. Au<strong>to</strong>logous<br />

haema<strong>to</strong>poietic stem cell transplantation for systemic lupus erythema<strong>to</strong>sus: data from the<br />

European Group for Blood and Marrow Transplantation registry. <strong>Lupus</strong> <strong>2012</strong>; PMID: 23257404


45. Bassi N, Luiset<strong>to</strong> R, Ghirardello A, Gat<strong>to</strong> M, Bottazzi B, Shoenfeld Y ,et al. Vaccination of<br />

mice for research purpose: alum is as effective as and safer than complete Freund adjuvant.<br />

Reumatismo <strong>2012</strong>;64:380-7. PMID: 23285482<br />

46. Rahman A. Can measuring urinary biomarkers improve the management of lupus nephritis?<br />

Arthritis Res Ther <strong>2012</strong>;14:127. PMID: 23256781<br />

47. Wang C, Ahlford A, Jarvinen TM, Nordmark G, Eloranta ML, Gunnarsson I ,et al. Genes<br />

identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J<br />

Hum Genet <strong>2012</strong>; PMID: 23249952<br />

48. Sanchez-Manubens J, Ortiz-Santamaria V, Coll Sibina MT, Cuquet J, Bermudez JR, Suris X<br />

,et al. Newborns whose mother has au<strong>to</strong>immune disease. A community hospitals' experience.<br />

Reuma<strong>to</strong>l Clin <strong>2012</strong>; PMID: 23265788<br />

49. Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA ,et al. New<br />

au<strong>to</strong>immune diseases after cord blood transplantation: a retrospective study of EUROCORD and<br />

the Au<strong>to</strong>immune Disease Working Party of EBMT. Blood <strong>2012</strong>; PMID: 23247725<br />

50. Chew C, Pember<strong>to</strong>n PW, Husain AA, Haque S, Bruce IN. Serum cystatin C is independently<br />

associated with renal impairment and high sensitivity C-reactive protein in systemic lupus<br />

erythema<strong>to</strong>sus. Clin Exp Rheuma<strong>to</strong>l <strong>2012</strong>; PMID: 23306163<br />

51. Hwang SH, Lee H, Yamamo<strong>to</strong> M, Jones LA, Dayalan J, Hopkins R ,et al. B cell TLR7<br />

expression drives anti-RNA au<strong>to</strong>antibody production and exacerbates disease in systemic lupus<br />

erythema<strong>to</strong>sus-prone mice. J Immunol <strong>2012</strong>;189:5786-96. PMID: 23150717<br />

52. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H ,et al. Interleukin-17 cy<strong>to</strong>kines are<br />

critical in development of fatal lupus glomerulonephritis. Immunity <strong>2012</strong>;37:1104-15. PMID:<br />

23123062<br />

53. Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, Toledano K, Markovits D, Rozin A ,et al.<br />

Rituximab: rescue therapy in life-threatening complications or refrac<strong>to</strong>ry au<strong>to</strong>immune diseases: a<br />

single center experience. Rheuma<strong>to</strong>l Int <strong>2012</strong>; PMID: 23239037<br />

54. Wang Q, Li X, Luo J, Zhang L, Ma L, Lv Z ,et al. The allogeneic umbilical cord<br />

mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheuma<strong>to</strong>id<br />

arthritis in an in vitro co-culture system. BMC Musculoskelet Disord <strong>2012</strong>;13:249. PMID:<br />

23237239<br />

55. Venner AA, Ibanez D, Gladman DD, Urowitz MB, Mackinnon A, Blasutig IM ,et al.<br />

Comparison of three anti-dsDNA assays: Performance and correlation with systemic lupus<br />

erythema<strong>to</strong>sus disease activity. Clin Biochem <strong>2012</strong>; PMID: 23246539<br />

56. Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF ,et al. Treatment for<br />

lupus nephritis. Cochrane Database Syst Rev <strong>2012</strong>;12:CD002922. PMID: 23235592


57. Mak A, Isenberg DA, Lau CS. Global trends, potential mechanisms and early detection of<br />

organ damage in SLE. Nat Rev Rheuma<strong>to</strong>l <strong>2012</strong>; PMID: 23229448<br />

58. Vachvanichsanong P, Dissaneewate P, McNeil E. Intravenous cyclophosphamide combined<br />

with steroids in pediatric onset severe lupus nephritis. Int Urol Nephrol <strong>2012</strong>; PMID: 23225077<br />

59. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H. Kidney biopsy is a sensitive <strong>to</strong>ol for<br />

retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant<br />

<strong>2012</strong>; PMID: 23223223<br />

60. Tarella C, Gueli A, Ruella M, Cignetti A. Lymphocyte transformation and au<strong>to</strong>immune<br />

disorders. Au<strong>to</strong>immun Rev <strong>2012</strong>; PMID: 23219771<br />

61. Stercz B, Nagy K, Ongradi J. [Adenovirus infections in immunocompromised patients]. Orv<br />

Hetil <strong>2012</strong>;153:1896-904. PMID: 23183005<br />

62. Gabriel CL, Smith PB, Mendez-Fernandez YV, Wilhelm AJ, Ye AM, Major AS.<br />

Au<strong>to</strong>immune-mediated glucose in<strong>to</strong>lerance in a mouse model of systemic lupus erythema<strong>to</strong>sus.<br />

Am J Physiol Endocrinol Metab <strong>2012</strong>;303:E1313-E1324. PMID: 23032686<br />

63. Lal SM. What can the management of kidney transplantation teach us about the management<br />

of lupus nephritis? Comment on the article by Hahn et al. Arthritis Care Res (Hoboken)<br />

<strong>2012</strong>;64:1936-7. PMID: 22933481<br />

64. Stratta P, Quaglia M. The other side of the risk equation: exploring the dangers of unplanned<br />

pregnancy in women with lupus nephritis. Comment on the article by Hahn et al. Arthritis Care<br />

Res (Hoboken) <strong>2012</strong>;64:1934-5. PMID: 22933305<br />

65. Yuan F, Nelson RK, Tabor DE, Zhang Y, Akhter MP, Gould KA ,et al. Dexamethasone<br />

prodrug treatment prevents nephritis in lupus-prone (NZB x NZW)F1 mice without causing<br />

systemic side effects. Arthritis Rheum <strong>2012</strong>;64:4029-39. PMID: 22886616<br />

66. Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. <strong>Lupus</strong><br />

nephritis: a critical review. Au<strong>to</strong>immun Rev <strong>2012</strong>;12:174-94. PMID: 22982174<br />

67. Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better<br />

diagnostic marker than anti-dsDNA antibodies for systemic lupus erythema<strong>to</strong>sus? A systematic<br />

review and a study of metanalysis. Au<strong>to</strong>immun Rev <strong>2012</strong>;12:97-106. PMID: 22810055<br />

68. Keller JJ, Chen YK, Lin HC. Comorbidities of bladder pain syndrome/interstitial cystitis: a<br />

population-based study. BJU Int <strong>2012</strong>;110:E903-E909. PMID: 23020942<br />

69. Ma AL, Lai WM, Chiu MC, Tse NK. A girl with difficult lupus nephritis: lupus<br />

vasculopathy. Clin Exp Nephrol <strong>2012</strong>;16:968-72. PMID: 23135867


70. Sekiuchi M, Kudo A, Nakabayashi K, Kanai-Azuma M, Akimo<strong>to</strong> Y, Kawakami H ,et al.<br />

Expression of matrix metalloproteinases 2 and 9 and tissue inhibi<strong>to</strong>rs of matrix<br />

metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies<br />

using immunofluorescence, in situ hybridization, and immunoelectron microscopy. Clin Exp<br />

Nephrol <strong>2012</strong>;16:863-74. PMID: 22614167<br />

71. Suzuki E, Karam E, Williams S, Watson DK, Gilkeson G, Zhang XK. Fli-1 transcription<br />

fac<strong>to</strong>r affects glomerulonephritis development by regulating expression of monocyte<br />

chemoattractant protein-1 in endothelial cells in the kidney. Clin Immunol <strong>2012</strong>;145:201-8.<br />

PMID: 23108091<br />

72. August P. Obstetric nephrology: pregnancy and the kidney--inextricably linked. Clin J Am<br />

Soc Nephrol <strong>2012</strong>;7:2071-2. PMID: 23221097<br />

73. Song YS, Min KW, Kim JH, Kim GH, Park MH. Differential diagnosis of lupus and primary<br />

membranous nephropathies by IgG subclass analysis. Clin J Am Soc Nephrol <strong>2012</strong>;7:1947-55.<br />

PMID: 23024158<br />

74. Stanhope TJ, White WM, Moder KG, Smyth A, Garovic VD. Obstetric nephrology: lupus<br />

and lupus nephritis in pregnancy. Clin J Am Soc Nephrol <strong>2012</strong>;7:2089-99. PMID: 22879437<br />

75. Lin H, Wei JC, Tan CY, Liu YY, Li YH, Li FX ,et al. Survival analysis of late-onset<br />

systemic lupus erythema<strong>to</strong>sus: a cohort study in China. Clin Rheuma<strong>to</strong>l <strong>2012</strong>;31:1683-9. PMID:<br />

22983769<br />

76. Hemmati I, Blocka K. Shrinking lung syndrome masked by pleuropericarditis: a case report<br />

and review of the literature. Clin Rheuma<strong>to</strong>l <strong>2012</strong>;31:1741-4. PMID: 22923179<br />

77. Mascarenhas S, Avalos B, Ardoin SP. An update on stem cell transplantation in au<strong>to</strong>immune<br />

rheuma<strong>to</strong>logic disorders. Curr Allergy Asthma Rep <strong>2012</strong>;12:530-40. PMID: 22956390<br />

78. Schickel JN, Pasquali JL, Soley A, Knapp AM, <strong>Dec</strong>ossas M, Kern A ,et al. Carabin<br />

deficiency in B cells increases BCR-TLR9 costimulation-induced au<strong>to</strong>immunity. EMBO Mol<br />

Med <strong>2012</strong>;4:1261-75. PMID: 23109291<br />

79. Mok CC. Abatacept for systemic lupus erythema<strong>to</strong>sus: the outlook. Expert Opin Biol Ther<br />

<strong>2012</strong>;12:1559-61. PMID: 22946545<br />

80. Tan H, Zhao J, Wang S, Zhang L, Wang H, Huang B ,et al. Ac-SDKP ameliorates the<br />

progression of lupus nephritis in MRL/lpr mice. Int Immunopharmacol <strong>2012</strong>;14:401-9. PMID:<br />

22922317<br />

81. Marina VP, Malhotra D, Kaw D. Hydralazine-induced ANCA vasculitis with pulmonary<br />

renal syndrome: a rare clinical presentation. Int Urol Nephrol <strong>2012</strong>;44:1907-9. PMID: 21590349


82. Lau M, Tsantikos E, Maxwell MJ, Tarlin<strong>to</strong>n DM, Anderson GP, Hibbs ML. Loss of STAT6<br />

promotes au<strong>to</strong>immune disease and a<strong>to</strong>py on a susceptible genetic background. J Au<strong>to</strong>immun<br />

<strong>2012</strong>;39:388-97. PMID: 22867713<br />

83. Xia Y, Pawar RD, Nakouzi AS, Herlitz L, Broder A, Liu K ,et al. The constant region<br />

contributes <strong>to</strong> the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. J<br />

Au<strong>to</strong>immun <strong>2012</strong>;39:398-411. PMID: 22841793<br />

84. Paunovic V, Carter NA, Thalhamer T, Blair D, Gordon B, Lacey E ,et al. Immune complexmediated<br />

co-ligation of the BCR with FcgammaRIIB results in homeostatic apop<strong>to</strong>sis of B cells<br />

involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus<br />

erythema<strong>to</strong>sus. J Au<strong>to</strong>immun <strong>2012</strong>;39:332-46. PMID: 22647731<br />

85. Zhang Y, Yang J, Jiang S, Fang C, Xiong L, Cheng H ,et al. The <strong>Lupus</strong>-derived Anti-doublestranded<br />

DNA IgG Contributes <strong>to</strong> Myofibroblast-like Phenotype in Mesangial Cells. J Clin<br />

Immunol <strong>2012</strong>;32:1270-8. PMID: 22730054<br />

86. Doria A, Gat<strong>to</strong> M. Nephri<strong>to</strong>genic-antinephri<strong>to</strong>genic antibody network in lupus<br />

glomerulonephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1492-6. PMID: 23042821<br />

87. Nyland JF, S<strong>to</strong>ll ML, Jiang F, Feng F, Gavalchin J. Mechanisms involved in the p62-73<br />

idiopeptide-modulated delay of lupus nephritis in SNF(1) mice. <strong>Lupus</strong> <strong>2012</strong>;21:1552-64. PMID:<br />

23015610<br />

88. Perazzio SF, Salomao R, Silva NP, Andrade LE. Increased neutrophil oxidative burst<br />

metabolism in systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:1543-51. PMID: 23012249<br />

89. Sheng YJ, Gao JP, Tang HY, Tang XF, Sun LD, Yin XY ,et al. A single-nucleotide<br />

polymorphism rs4639966 in 11q23.3 is associated with clinical features of systemic lupus<br />

erythema<strong>to</strong>sus in the Chinese population. <strong>Lupus</strong> <strong>2012</strong>;21:1538-42. PMID: 23002088<br />

90. Sprangers B, Monahan M, Appel GB. Diagnosis and treatment of lupus nephritis flares--an<br />

update. Nat Rev Nephrol <strong>2012</strong>;8:709-17. PMID: 23147758<br />

91. Lateef A, Petri M. Management of pregnancy in systemic lupus erythema<strong>to</strong>sus. Nat Rev<br />

Rheuma<strong>to</strong>l <strong>2012</strong>;8:710-8. PMID: 22907290<br />

92. Thomasova D, Mulay SR, Bruns H, Anders HJ. p53-Independent Roles of MDM2 in NFkappaB<br />

Signaling: Implications for Cancer Therapy, Wound Healing, and Au<strong>to</strong>immune<br />

Diseases. Neoplasia <strong>2012</strong>;14:1097-101. PMID: 23308042<br />

93. Paccosi S, Musilli C, Mangano G, Guglielmotti A, Parenti A. The monocyte chemotactic<br />

protein synthesis inhibi<strong>to</strong>r bindarit prevents mesangial cell proliferation and extracellular matrix<br />

remodeling. Pharmacol Res <strong>2012</strong>;66:526-35. PMID: 22982961


94. Haddock NT, Saadeh PB, Siebert JW. Achieving aesthetic results in facial reconstructive<br />

microsurgery: planning and executing secondary refinements. Plast Reconstr Surg<br />

<strong>2012</strong>;130:1236-45. PMID: 23190808<br />

95. Dhillon A, Velazquez C, Siva C. Rheuma<strong>to</strong>logic diseases and posterior reversible<br />

encephalopathy syndrome: two case reports and review of the literature. Rheuma<strong>to</strong>l Int<br />

<strong>2012</strong>;32:3707-13. PMID: 22825304<br />

96. Wang FM, Yu F, Tan Y, Song D, Zhao MH. Serum complement fac<strong>to</strong>r H is associated with<br />

clinical and pathological activities of patients with lupus nephritis. Rheuma<strong>to</strong>logy (Oxford)<br />

<strong>2012</strong>;51:2269-77. PMID: 22956549<br />

97. Lee SW, Park YB, Yang J, Park KH, Lee SK, Choi KH ,et al. Attenuation of nephritis in<br />

lupus-prone mice by thalidomide. Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>;51:2131-40. PMID: 22923758<br />

98. Haubitz M. [<strong>Lupus</strong>nephritis]. Z Rheuma<strong>to</strong>l <strong>2012</strong>;71:875-84. PMID: 23202997<br />

99. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcon GS ,et al. Epidemiology<br />

and sociodemographics of systemic lupus erythema<strong>to</strong>sus and lupus nephritis among U.S. adults<br />

with medicaid coverage, 2000-2004. Arthritis Rheum <strong>2012</strong>; PMID: 23203603<br />

100. Ichinose K, Zhang Z, Koga T, Juang YT, Kis-Toth K, Sharpe AH ,et al. Increased<br />

expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice. Arthritis<br />

Rheum <strong>2012</strong>; PMID: 23203389<br />

101. Okpechi IG, Ayodele OE, Rayner BL, Swanepoel CR. Kidney disease in elderly South<br />

Africans. Clin Nephrol <strong>2012</strong>; PMID: 23195833<br />

102. Lee H, Kim H, Lee G, Chung HS, Bae H. Curcumin attenuates lupus nephritis upon<br />

interaction with regula<strong>to</strong>ry T cells in New Zealand Black/White mice. Br J Nutr <strong>2012</strong>;1-8.<br />

PMID: 23181951<br />

103. Sahin OZ, Gurses S, Tasli F, Yavas H, Ersoy R, Uzum A ,et al. Glomerular C4d Staining<br />

Can Be an Indica<strong>to</strong>r of Disease Activity in <strong>Lupus</strong> <strong>Nephritis</strong>. Ren Fail <strong>2012</strong>; PMID: 23176021<br />

104. Cipriani P, Carubbi F, Liakouli V, Marrelli A, Perricone C, Perricone R ,et al. Stem cells in<br />

au<strong>to</strong>immune diseases: Implications for pathogenesis and future trends in therapy. Au<strong>to</strong>immun<br />

Rev <strong>2012</strong>; PMID: 23183379<br />

105. Punaro MG. The treatment of systemic lupus proliferative nephritis. Pediatr Nephrol <strong>2012</strong>;<br />

PMID: 23179192<br />

106. Treamtrakanpon W, Tantivitayakul P, Benjachat T, Somparn P, Kittikowit W, Eiam-Ong S<br />

,et al. APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis. Arthritis<br />

Res Ther <strong>2012</strong>;14:R252. PMID: 23171638


107. Gutierrez T, Mayeux JM, Ortega SB, Karandikar NJ, Li QZ, Rakheja D ,et al. IL-21<br />

promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn(-/-) mice.<br />

Eur J Immunol <strong>2012</strong>; PMID: 23169140<br />

108. Xue M, Zhao Y, Li XJ, Jiang ZZ, Zhang L, Liu SH ,et al. Comparison of <strong>to</strong>xicokinetic and<br />

tissue distribution of trip<strong>to</strong>lide-loaded solid lipid nanoparticles vs free trip<strong>to</strong>lide in rats. Eur J<br />

Pharm Sci <strong>2012</strong>;47:713-7. PMID: 22677813<br />

109. Dung NT, Loan HT, Nielsen S, Zak M, Petersen FK. Juvenile systemic lupus erythema<strong>to</strong>sus<br />

onset patterns in Vietnamese children: a descriptive study of 45 children. Pediatr Rheuma<strong>to</strong>l<br />

Online J <strong>2012</strong>;10:38. PMID: 23164451<br />

110. Ribeiro FM, Fabris CL, Bendet I, Lugon JR. Survival of lupus patients on dialysis: a<br />

Brazilian cohort. Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>; PMID: 23148092<br />

111. Yap DY, Ma MK, Mok MM, Tang CS, Chan TM. Long-term data on corticosteroids and<br />

mycophenolate mofetil treatment in lupus nephritis. Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>; PMID:<br />

23148090<br />

112. Munoz SA, Aranda F, Allievi A, Orden AO, Peres WS, Trobo R ,et al. 4G/5G plasminogen<br />

activa<strong>to</strong>r inhibi<strong>to</strong>r-1 and -308 A/G tumor necrosis fac<strong>to</strong>r-alpha promoter gene polymorphisms in<br />

Argentinean lupus patients: focus on lupus nephritis. Clin Exp Med <strong>2012</strong>; PMID: 23143392<br />

113. Shariati-Sarabi Z, Monzavi SM, Ranjbar A, Esmaily H, Etemadrezaie H. High disease<br />

activity is associated with high disease damage in an Iranian inception cohort of patients with<br />

lupus nephritis. Clin Exp Rheuma<strong>to</strong>l <strong>2012</strong>; PMID: 23190627<br />

114. Giocanti-Auregan A, Grenet T, Rohart C, Badelon I, Chaine G. Inaugural severe vasoocclusive<br />

retinopathy in systemic lupus erythema<strong>to</strong>sus. Int Ophthalmol <strong>2012</strong>; PMID: 23124274<br />

115. Gale DP, Maxwell PH. C3 glomerulonephritis and CFHR5 nephropathy. Nephrol Dial<br />

Transplant <strong>2012</strong>; PMID: 23125424<br />

116. Bertsias GK, Tek<strong>to</strong>nidou M, Amoura Z, Aringer M, Bajema I, Berden JH ,et al. Joint<br />

European League Against Rheumatism and European Renal Association-European Dialysis and<br />

Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult<br />

and paediatric lupus nephritis. Ann Rheum Dis <strong>2012</strong>;71:1771-82. PMID: 22851469<br />

117. Manzi S, Sanchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV ,et al. Effects of<br />

belimumab, a B lymphocyte stimula<strong>to</strong>r-specific inhibi<strong>to</strong>r, on disease activity across multiple<br />

organ domains in patients with systemic lupus erythema<strong>to</strong>sus: combined results from two phase<br />

III trials. Ann Rheum Dis <strong>2012</strong>;71:1833-8. PMID: 22550315<br />

118. Chogle AR. Major infections including tuberculosis as a primary risk fac<strong>to</strong>r for poor<br />

outcome of lupus nephritis in Asian Indians: comment on the article by Dhir et al. Arthritis Care<br />

Res (Hoboken) <strong>2012</strong>;64:1783-4. PMID: 22833501


119. Xiao ZY, Chen SH, Cheng JP, Zhou WX, Zhang YX, Yang RF ,et al. Y27, a novel<br />

derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic<br />

lupus erythema<strong>to</strong>sus-like diseases in MRL/lpr au<strong>to</strong>immune mice and BDF1 hybrid mice.<br />

Arthritis Res Ther <strong>2012</strong>;14:R235. PMID: 23116248<br />

120. Sanchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD ,et al.<br />

Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic<br />

lupus erythema<strong>to</strong>sus in American Indian-European populations. Arthritis Rheum <strong>2012</strong>;64:3687-<br />

94. PMID: 22886787<br />

121. Wofsy D, Hillson JL, Diamond B. Abatacept for lupus nephritis: alternative definitions of<br />

complete response support conflicting conclusions. Arthritis Rheum <strong>2012</strong>;64:3660-5. PMID:<br />

22806274<br />

122. Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M.<br />

Identification of a major linear C1q epi<strong>to</strong>pe allows detection of systemic lupus erythema<strong>to</strong>sus<br />

anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis<br />

Rheum <strong>2012</strong>;64:3706-14. PMID: 22740328<br />

123. Filippini P, Del PN, Sambataro D, Del BA, Locatelli F, Rutella S. Emerging concepts on<br />

inhibi<strong>to</strong>rs of indoleamine 2,3-dioxygenase in rheumatic diseases. Curr Med Chem <strong>2012</strong>;19:5381-<br />

93. PMID: 22963664<br />

124. Barbado J, Martin D, Vega L, Almansa R, Goncalves L, Noci<strong>to</strong> M ,et al. MCP-1 in urine as<br />

biomarker of disease activity in Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus. Cy<strong>to</strong>kine <strong>2012</strong>;60:583-6.<br />

PMID: 22857869<br />

125. Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M. Serum<br />

cy<strong>to</strong>kine profile in patients with active lupus nephritis. Cy<strong>to</strong>kine <strong>2012</strong>;60:410-6. PMID:<br />

22846145<br />

126. Ferraccioli G, Gremese E. [Class IV-G and IV-S lupus nephritis, interstitial infiltrates and<br />

prognosis: state of the art and unmet medical needs]. G Ital Nefrol <strong>2012</strong>;29:655-60. PMID:<br />

23229663<br />

127. Palit A, Inamadar AC. Current treatment strategies: collagen vascular diseases in children.<br />

Indian J Derma<strong>to</strong>l <strong>2012</strong>;57:449-58. PMID: 23248363<br />

128. Otani M, Kuroki A, Kikuchi S, Kihara M, Nakata J, I<strong>to</strong> K ,et al. Sialylation determines the<br />

nephri<strong>to</strong>genicity of IgG3 cryoglobulins. J Am Soc Nephrol <strong>2012</strong>;23:1869-78. PMID: 23024299<br />

129. Yongsiri S, Thammakumpee J, Annanon N. SLE with diffuse alveolar hemorrhage,<br />

microangiopathic hemolytic anemia and acute renal failure. J Clin Apher <strong>2012</strong>;27:263-4. PMID:<br />

22730045


130. Paripovic D, Kostic M, Kruscic D, Spasojevic B, Lomic G, Markovic-Lipkovski J ,et al.<br />

Indications and results of renal biopsy in children: a 10-year review from a single center in<br />

Serbia. J Nephrol <strong>2012</strong>;25:1054-9. PMID: 22383346<br />

131. Frieri M, Samih MA, Dzhindzhikhashvili M, Liu H, Balsam L, Rubinstein S. Toll-like<br />

recep<strong>to</strong>r 9 and vascular endothelial growth fac<strong>to</strong>r levels in human kidneys from lupus nephritis<br />

patients. J Nephrol <strong>2012</strong>;25:1041-6. PMID: 22344539<br />

132. Fischer-Betz R, Chehab G, Sander O, Vordenbaumen S, Voiculescu A, Brinks R ,et al.<br />

Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly<br />

intravenous cyclophosphamide: a prospective observational study. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:2111-7.<br />

PMID: 22984276<br />

133. Zirkzee EJ, Steup-Beekman GM, van der Mast RC, Bollen EL, van der Wee NJ, Baptist E<br />

,et al. Prospective study of clinical phenotypes in neuropsychiatric systemic lupus<br />

erythema<strong>to</strong>sus; multidisciplinary approach <strong>to</strong> diagnosis and therapy. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:2118-<br />

26. PMID: 22984275<br />

134. Ooi JD, Kitching AR. CD4+ Th1 cells are effec<strong>to</strong>rs in lupus nephritis--but what are their<br />

targets? Kidney Int <strong>2012</strong>;82:947-9. PMID: 23064187<br />

135. Okamo<strong>to</strong> A, Fujio K, Tsuno NH, Takahashi K, Yamamo<strong>to</strong> K. Kidney-infiltrating CD4+ T-<br />

cell clones promote nephritis in lupus-prone mice. Kidney Int <strong>2012</strong>;82:969-79. PMID: 22763816<br />

136. Kofman T, Narjoz C, Raimbourg Q, Loriot MA, Karras A, Roland M ,et al. Collapsing<br />

glomerulopathy associated lupus in a black female with homozygous APOL1 mutation. <strong>Lupus</strong><br />

<strong>2012</strong>;21:1459-62. PMID: 22952321<br />

137. Pons-Estel GJ, Saurit V, Alarcon GS, Hachuel L, Boggio G, Wojdyla D ,et al. The impact<br />

of rural residency on the expression and outcome of systemic lupus erythema<strong>to</strong>sus: data from a<br />

multiethnic Latin American cohort. <strong>Lupus</strong> <strong>2012</strong>;21:1397-404. PMID: 22941567<br />

138. Wang YF, Xu YX, Tan Y, Yu F, Zhao MH. Clinicopathological characteristics and<br />

outcomes of male lupus nephritis in China. <strong>Lupus</strong> <strong>2012</strong>;21:1472-81. PMID: 22898536<br />

139. Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL. The potential role of Th17<br />

cells and Th17-related cy<strong>to</strong>kines in the pathogenesis of lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1385-96.<br />

PMID: 22892208<br />

140. Yap DY, Ma MK, Tang CS, Chan TM. Proliferation signal inhibi<strong>to</strong>rs in the treatment of<br />

lupus nephritis: preliminary experience. Nephrology (Carl<strong>to</strong>n) <strong>2012</strong>;17:676-80. PMID:<br />

22817609<br />

141. Regent A, Kluger N, Berezne A, Lassoued K, Mouthon L. [Lymphocy<strong>to</strong>penia: aetiology<br />

and diagnosis, when <strong>to</strong> think about idiopathic CD4(+) lymphocy<strong>to</strong>penia?]. Rev Med Interne<br />

<strong>2012</strong>;33:628-34. PMID: 22658164


142. Sui W, Tang D, Zou G, Chen J, Ou M, Zhang Y ,et al. Differential proteomic analysis of<br />

renal tissue in lupus nephritis using iTRAQ reagent technology. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:3537-43.<br />

PMID: 22083613<br />

143. Gupta R, Sharma A, Gupta R, Agarwal SK, Dinda AK. Morphometry of non-inflamma<strong>to</strong>ry<br />

arteriolar changes in lupus nephritis: a study of 40 cases. Saudi J Kidney Dis Transpl<br />

<strong>2012</strong>;23:1196-201. PMID: 23168848<br />

144. Wang D, Zhang H, Liang J, Li X, Feng X, Wang H ,et al. Allogeneic mesenchymal stem<br />

cell transplantation in severe and refrac<strong>to</strong>ry systemic lupus erythema<strong>to</strong>sus: 4 years experience.<br />

Cell Transplant <strong>2012</strong>; PMID: 23127470<br />

145. Ma X, Che N, Gu Z, Huang J, Wang D, Liang J ,et al. Allogenic mesenchymal stem cell<br />

transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell<br />

Transplant <strong>2012</strong>; PMID: 23127285<br />

146. Sui M, Lin Q, Xu Z, Han X, Xie R, Jia X ,et al. Simultaneous Positivity for Anti-DNA,<br />

Anti-Nucleosome and Anti-His<strong>to</strong>ne Antibodies is a Marker for More Severe <strong>Lupus</strong> <strong>Nephritis</strong>. J<br />

Clin Immunol <strong>2012</strong>; PMID: 23100145<br />

147. Miettunen PM, Pis<strong>to</strong>rio A, Palmisani E, Ravelli A, Silverman E, Oliveira S ,et al.<br />

Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus<br />

erythema<strong>to</strong>sus: an international multicentre PRINTO study. Ann Rheum Dis <strong>2012</strong>; PMID:<br />

23100607<br />

148. Campbell AM, Kashgarian M, Shlomchik MJ. NADPH oxidase inhibits the pathogenesis of<br />

systemic lupus erythema<strong>to</strong>sus. Sci Transl Med <strong>2012</strong>;4:157ra141. PMID: 23100627<br />

149. Akiyama K, You YO, Yamaza T, Chen C, Tang L, Jin Y ,et al. Characterization of bone<br />

marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther <strong>2012</strong>;3:40. PMID:<br />

23083975<br />

150. Glassock RJ, Khorashadi L, Kushner YB. Case records of the Massachusetts General<br />

Hospital. Case 32-<strong>2012</strong>. A 35-year-old man with respira<strong>to</strong>ry and renal failure. N Engl J Med<br />

<strong>2012</strong>;367:1540-53. PMID: 23075181<br />

151. Li X, Wang D, Liang J, Zhang H, Sun L. Mesenchymal SCT ameliorates refrac<strong>to</strong>ry<br />

cy<strong>to</strong>penia in patients with systemic lupus erythema<strong>to</strong>sus. Bone Marrow Transplant <strong>2012</strong>; PMID:<br />

23064040<br />

152. Bockle BC, Stanarevic G, Sepp NT. Detection of Ro/SS-A antibodies in lupus<br />

erythema<strong>to</strong>sus: What does it mean for the derma<strong>to</strong>logist? J Am Acad Derma<strong>to</strong>l <strong>2012</strong>; PMID:<br />

23069705


153. Santucci L, Candiano G, Bruschi M, Bodria M, Murtas C, Petret<strong>to</strong> A ,et al. Urinary<br />

proteome in a snapshot: normal urine and glomerulonephritis. J Nephrol <strong>2012</strong>;0. PMID:<br />

23065920<br />

154. Tani C, D'Aniello D, Sedie AD, Carli L, Cagnoni M, Possema<strong>to</strong> N ,et al. Rhupus syndrome:<br />

Assessment of its prevalence and its clinical and instrumental characteristics in a prospective<br />

cohort of 103 SLE patients. Au<strong>to</strong>immun Rev <strong>2012</strong>; PMID: 23063507<br />

155. Wen YK, Wen KI. An unusual cause of non-infectious peri<strong>to</strong>nitis in a peri<strong>to</strong>neal dialysis<br />

patient. Int Urol Nephrol <strong>2012</strong>; PMID: 23054326<br />

156. Rubio-Rivas M, Gomez-Junyent J, Simonetti A, Mitjavila F, Capdevila O, Pujol R.<br />

[Proliferative mesangial lupus nephritis: description of a cohort of 27 patients]. Med Clin (Barc)<br />

<strong>2012</strong>;139:341-5. PMID: 22401733<br />

157. Fukami K, Yamagishi SI, Minezaki T, Nishi S, Hisano S, Okuda S. First reported case of<br />

collagenofibrotic glomerulopathy with a full-house pattern of immune deposits. Clin Nephrol<br />

<strong>2012</strong>; PMID: 23036230<br />

158. Kurnia E, Hardi F, Dewiasty E. Digital gangrene in systemic lupus erythema<strong>to</strong>sus. Acta<br />

Med Indones <strong>2012</strong>;44:335-6. PMID: 23314976<br />

159. Moroni G, Gallelli B, Sinico RA, Romano G, Sinigaglia L, Messa P. Rituximab versus oral<br />

cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical<br />

observational study. Ann Rheum Dis <strong>2012</strong>;71:1751-2. PMID: 22586177<br />

160. Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E ,et al. European genetic<br />

ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum <strong>2012</strong>;64:3374-82.<br />

PMID: 23023776<br />

161. Kirou KA, Gkrouzman E, Chevalier JM, Seshan SV. Antiinflamma<strong>to</strong>ry strategies, not just<br />

B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis:<br />

comment on the article by Rovin et al. Arthritis Rheum <strong>2012</strong>;64:3486. PMID: 22777724<br />

162. Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW ,et al.<br />

Transplantation for au<strong>to</strong>immune diseases in north and South America: a report of the Center for<br />

International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant<br />

<strong>2012</strong>;18:1471-8. PMID: 22705497<br />

163. Aizawa-Yashiro T, Tsuruga K, Watanabe S, Echizenya T, I<strong>to</strong> E, Tanaka H. Long-term<br />

multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less<br />

cy<strong>to</strong><strong>to</strong>xic therapy. Clin Nephrol <strong>2012</strong>;78:332-4. PMID: 22854164<br />

164. Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C ,et al. Genetic<br />

inhibition of discoidin domain recep<strong>to</strong>r 1 protects mice against crescentic glomerulonephritis.<br />

FASEB J <strong>2012</strong>;26:4079-91. PMID: 22751008


165. Rose AM, Bell LC. Epistasis and immunity: the role of genetic interactions in au<strong>to</strong>immune<br />

diseases. Immunology <strong>2012</strong>;137:131-8. PMID: 22804709<br />

166. Herbst R, Liu Z, Jallal B, Yao Y. Biomarkers for systemic lupus erythema<strong>to</strong>sus. Int J<br />

Rheum Dis <strong>2012</strong>;15:433-44. PMID: 23083033<br />

167. Hong JY, Lai CC, Chang YS, Hsiao KH, Chou CT, Chen WS. Intestinal vasculitis and renal<br />

infarction in a lupus patient with antiphospholipid syndrome. J Clin Rheuma<strong>to</strong>l <strong>2012</strong>;18:383.<br />

PMID: 22832302<br />

168. Koga T, Ichinose K, Mizui M, Crispin JC, Tsokos GC. Calcium/calmodulin-dependent<br />

protein kinase IV suppresses IL-2 production and regula<strong>to</strong>ry T cell activity in lupus. J Immunol<br />

<strong>2012</strong>;189:3490-6. PMID: 22942433<br />

169. Rosetti F, Tsuboi N, Chen K, Nishi H, Ernandez T, Sethi S ,et al. Human lupus serum<br />

induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J<br />

Immunol <strong>2012</strong>;189:3714-23. PMID: 22933624<br />

170. Huang CF, Chen PL, Liu MF, Lee CC, Lee NY, Chang CM ,et al. Nontyphoidal Salmonella<br />

bacteremia in patients with connective tissue diseases. J Microbiol Immunol Infect <strong>2012</strong>;45:350-<br />

5. PMID: 22571997<br />

171. Rosa RF, Takei K, Araujo NC, Loduca SM, Szajubok JC, Chahade WH. Monocyte<br />

chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in<br />

Brazilian patients. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:1948-54. PMID: 22942263<br />

172. Lu J, Sze<strong>to</strong> CC, Tam LS, Lai FM, Li EK, Chow KM ,et al. Relationship of intrarenal gene<br />

expression and the his<strong>to</strong>logical class of lupus nephritis -- a study on repeat renal biopsy. J<br />

Rheuma<strong>to</strong>l <strong>2012</strong>;39:1942-7. PMID: 22896023<br />

173. Bramham K, Soh MC, Nelson-Piercy C. Pregnancy and renal outcomes in lupus nephritis:<br />

an update and guide <strong>to</strong> management. <strong>Lupus</strong> <strong>2012</strong>;21:1271-83. PMID: 22878255<br />

174. Vadasz Z, Toubi E. Semaphorin 3A - a marker for disease activity and a potential putative<br />

disease-modifying treatment in systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:1266-70. PMID:<br />

22875653<br />

175. Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM. Juvenile onset<br />

systemic lupus erythema<strong>to</strong>sus: a possible role for vitamin D in disease status and bone health.<br />

<strong>Lupus</strong> <strong>2012</strong>;21:1335-42. PMID: 22833435<br />

176. Touma Z, Gladman DD, Ibanez D, Urowitz MB. SLEDAI-2K Responder Index 50 captures<br />

50% improvement in disease activity over 10 years. <strong>Lupus</strong> <strong>2012</strong>;21:1305-11. PMID: 22800940<br />

177. Moysiadis DK, Perysinaki GS, Bertsias G, Stratakis S, Kyriacou K, Nakopoulou L ,et al.<br />

Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins


nephrin and podocin in experimental lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1196-207. PMID:<br />

22767414<br />

178. Singh RG, Usha, Rathore SS, Behura SK, Singh NK. Urinary MCP-1 as diagnostic and<br />

prognostic marker in patients with lupus nephritis flare. <strong>Lupus</strong> <strong>2012</strong>;21:1214-8. PMID:<br />

22759858<br />

179. Sule S, Fivush B, Neu A, Furth S. Increased hospitalizations and death in patients with<br />

ESRD secondary <strong>to</strong> lupus. <strong>Lupus</strong> <strong>2012</strong>;21:1208-13. PMID: 22736748<br />

180. Guan J, Wang G, Tam LS, Kwan BC, Li EK, Chow KM ,et al. Urinary sediment ICAM-1<br />

level in lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1190-5. PMID: 22685016<br />

181. Malviya G, Anzola KL, Podesta E, Lagana B, Del MC, Dierckx RA ,et al. (99m)Tc-labeled<br />

rituximab for imaging B lymphocyte infiltration in inflamma<strong>to</strong>ry au<strong>to</strong>immune disease patients.<br />

Mol Imaging Biol <strong>2012</strong>;14:637-46. PMID: 22127469<br />

182. Streck AS, Staub HL, de Freitas CZ, Marrone L, Costa J, Gadonski G. Posterior reversible<br />

encephalopathy syndrome (PRES) and systemic lupus erythema<strong>to</strong>sus: report of two cases. Rev<br />

Bras Reuma<strong>to</strong>l <strong>2012</strong>;52:804-10. PMID: 23090381<br />

183. Hervier B, Hamidou M, Haroche J, Durant C, Mathian A, Amoura Z. Systemic lupus<br />

erythema<strong>to</strong>sus associated with ANCA-associated vasculitis: an overlapping syndrome?<br />

Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:3285-90. PMID: 21805174<br />

184. Yee CS, Akil M, Khamashta M, Bessant R, Kilding R, Giles I ,et al. The BILAG2004-<br />

Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients.<br />

Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>;51:1877-80. PMID: 22763989<br />

185. Zhou JQ, Jiang H. [Feasibility of SLEDAI-2000 and BILAG-2004 scoring systems for<br />

assessing renal disease activity in children with lupus nephritis]. Zhongguo Dang Dai Er Ke Za<br />

Zhi <strong>2012</strong>;14:775-9. PMID: 23092572<br />

186. Ladriere M. [Current indications of azathioprine in nephrology.]. Nephrol Ther <strong>2012</strong>;<br />

PMID: 23022291<br />

187. Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J ,et al. Clinical<br />

associations of the metabolic syndrome in systemic lupus erythema<strong>to</strong>sus: data from an<br />

international inception cohort. Ann Rheum Dis <strong>2012</strong>; PMID: 22945501<br />

188. Arabi MT, Malek EM, Fares MH, Itani MH. Cardiac tamponade as the first manifestation of<br />

systemic lupus erythema<strong>to</strong>sus in children. BMJ Case Rep <strong>2012</strong>;<strong>2012</strong>: PMID: 23001107<br />

189. Tullus K, Marks SD. Indications for use and safety of rituximab in childhood renal diseases.<br />

Pediatr Nephrol <strong>2012</strong>; PMID: 22992983


190. Kattah AG, Fervenza FC, Roccatello D. Rituximab-based novel strategies for the treatment<br />

of immune-mediated glomerular diseases. Au<strong>to</strong>immun Rev <strong>2012</strong>; PMID: 23000633<br />

191. Hu SC, Lin CL, Lu YW, Chen GS, Yu HS, Wu CS ,et al. Lymphopaenia, Anti-Ro/Anti-<br />

RNP Au<strong>to</strong>antibodies, Renal Involvement and Cyclophosphamide Use Correlate with Increased<br />

Risk of Herpes Zoster in Patients with Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus. Acta Derm Venereol<br />

<strong>2012</strong>; PMID: 22983107<br />

192. Cui JT, Ni AP, Wu YL, Kong LJ, Yan WJ, Li Q ,et al. [Analysis of cy<strong>to</strong>megaloviral<br />

antigenemia test and re-test after antiviral chemotherapy in patients with au<strong>to</strong>immune and nonau<strong>to</strong>immune<br />

diseases]. Zhonghua Yi Xue Za Zhi <strong>2012</strong>;92:2426-9. PMID: 23158667<br />

193. Kang SC, Hwang SJ, Chang YS, Chou CT, Tsai CY. Characteristics of comorbidities and<br />

costs among patients who died from systemic lupus erythema<strong>to</strong>sus in Taiwan. Arch Med Sci<br />

<strong>2012</strong>;8:690-6. PMID: 23056082<br />

194. Piotrowski P, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP. Contribution of <strong>to</strong>lllike<br />

recep<strong>to</strong>r 9 gene single-nucleotide polymorphism <strong>to</strong> systemic lupus erythema<strong>to</strong>sus.<br />

Rheuma<strong>to</strong>l Int <strong>2012</strong>; PMID: 22948541<br />

195. Di DJ, Dorta-Estremera S, Gagea M, Ganguly D, Meller S, Li P ,et al. Nucleic acidcontaining<br />

amyloid fibrils potently induce type I interferon and stimulate systemic<br />

au<strong>to</strong>immunity. Proc Natl Acad Sci U S A <strong>2012</strong>;109:14550-5. PMID: 22904191<br />

196. Chan T, Mak HK, Kwong YL. Generalized lymph node immunoglobulin G amyloidoma.<br />

Ann Hema<strong>to</strong>l <strong>2012</strong>;91:1503-4. PMID: 22314842<br />

197. Alayoud A, Qamouss O, Hamzi A, Benyahia M, Oualim Z. Scleroderma renal crisis<br />

precipitated by steroid treatment in systemic lupus erythema<strong>to</strong>sus and scleroderma overlap<br />

syndrome. Arab J Nephrol Transplant <strong>2012</strong>;5:153-7. PMID: 22967254<br />

198. Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL ,et al. Cyclophosphamide and 4-<br />

hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary <strong>to</strong><br />

lupus and small vessel vasculitis. Br J Clin Pharmacol <strong>2012</strong>;74:445-55. PMID: 22380717<br />

199. Chen Z, Wang GS, Wang GH, Li XP. Anti-C1q antibody is a valuable biological marker for<br />

prediction of renal pathological characteristics in lupus nephritis. Clin Rheuma<strong>to</strong>l <strong>2012</strong>;31:1323-<br />

9. PMID: 22696012<br />

200. Coca A, Sanz I. <strong>Update</strong>s on B-cell immunotherapies for systemic lupus erythema<strong>to</strong>sus and<br />

Sjogren's syndrome. Curr Opin Rheuma<strong>to</strong>l <strong>2012</strong>;24:451-6. PMID: 22871954<br />

201. Ornstein BW, Atkinson JP, Densen P. The complement system in pediatric systemic lupus<br />

erythema<strong>to</strong>sus, atypical hemolytic uremic syndrome, and complocentric<br />

membranoglomerulopathies. Curr Opin Rheuma<strong>to</strong>l <strong>2012</strong>;24:522-9. PMID: 22810363


202. Kulkarni OP, Anders HJ. <strong>Lupus</strong> nephritis. How latest insights in<strong>to</strong> its pathogenesis promote<br />

novel therapies. Curr Opin Rheuma<strong>to</strong>l <strong>2012</strong>;24:457-65. PMID: 22810362<br />

203. Zou X, Cheng H, Zhang Y, Fang C, Xia Y. The antigen-binding fragment of anti-doublestranded<br />

DNA IgG enhances F-actin formation in mesangial cells by binding <strong>to</strong> alpha-actinin-4.<br />

Exp Biol Med (Maywood ) <strong>2012</strong>;237:1023-31. PMID: 22929799<br />

204. Gan H, Feng S, Wu H, Sun Y, Hu R, Zhao Z ,et al. Neonatal Fc recep<strong>to</strong>r stimulation<br />

induces ubiquitin c-terminal hydrolase-1 overexpression in podocytes through activation of p38<br />

mi<strong>to</strong>gen-activated protein kinase. Hum Pathol <strong>2012</strong>;43:1482-90. PMID: 22406365<br />

205. Raphael V, Gogoi P, Khonglah Y, Lynrah KG, Dass R. Spectrum of renal lesions in<br />

systemic lupus erythema<strong>to</strong>sus: Six years' experience at a tertiary health care centre in north east<br />

India. Indian J Nephrol <strong>2012</strong>;22:399-400. PMID: 23326058<br />

206. Das U, Dakshinamurty KV, Prayaga A, Uppin MS. Nondiabetic kidney disease in type 2<br />

diabetic patients: A single center experience. Indian J Nephrol <strong>2012</strong>;22:358-62. PMID:<br />

23326046<br />

207. Pradhan V, Rajadhyaksha A, Mahant G, Surve P, Patwardhan M, Dighe S ,et al. Anti-C1q<br />

antibodies and their association with complement components in Indian systemic lupus<br />

erythema<strong>to</strong>sus patients. Indian J Nephrol <strong>2012</strong>;22:353-7. PMID: 23326045<br />

208. Michaelson JS, Wisniacki N, Burkly LC, Putterman C. Role of TWEAK in lupus nephritis:<br />

a bench-<strong>to</strong>-bedside review. J Au<strong>to</strong>immun <strong>2012</strong>;39:130-42. PMID: 22727560<br />

209. Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY ,et al. Bone marrow of<br />

NZB/W mice is the major site for plasma cells resistant <strong>to</strong> dexamethasone and<br />

cyclophosphamide: implications for the treatment of au<strong>to</strong>immunity. J Au<strong>to</strong>immun <strong>2012</strong>;39:180-<br />

8. PMID: 22727274<br />

210. Yesilada AK, Sevim KZ, Sirvan SS, Irmak F, Tatlidede HS. Severe symmetrical facial<br />

lipoatrophy in a patient with discoid lupus erythema<strong>to</strong>sus. J Craniofac Surg <strong>2012</strong>;23:e461-e463.<br />

PMID: 22976708<br />

211. Urisman A, Leard LE, Nathan M, Elicker BM, Hoopes C, Kukreja J ,et al. Rapidly<br />

progressive pulmonary venoocclusive disease in young women taking oral contraceptives. J<br />

Heart Lung Transplant <strong>2012</strong>;31:1031-6. PMID: 22884388<br />

212. Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q antibodies in patients<br />

with lupus nephritis: a meta-analysis. <strong>Lupus</strong> <strong>2012</strong>;21:1088-97. PMID: 22777943<br />

213. Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S. Gene expression of<br />

cy<strong>to</strong>kines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic<br />

lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:1105-12. PMID: 22759859


214. Alonso MD, Martinez-Vazquez F, de Teran TD, Miranda-Filloy JA, Dierssen T, Blanco R<br />

,et al. Late-onset systemic lupus erythema<strong>to</strong>sus in Northwestern Spain: differences with earlyonset<br />

systemic lupus erythema<strong>to</strong>sus and literature review. <strong>Lupus</strong> <strong>2012</strong>;21:1135-48. PMID:<br />

22652632<br />

215. Zheng ZH, Zhang LJ, Liu WX, Lei YS, Xing GL, Zhang JJ ,et al. Predic<strong>to</strong>rs of survival in<br />

Chinese patients with lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1049-56. PMID: 22513365<br />

216. Renau AI, Isenberg DA. Male versus female lupus: a comparison of ethnicity, clinical<br />

features, serology and outcome over a 30 year period. <strong>Lupus</strong> <strong>2012</strong>;21:1041-8. PMID: 22505605<br />

217. Rathi M, Ramachandran R, Gundlapalli S, Agarwal R, Das A, Kumar V ,et al. Rituximab<br />

induced pulmonary fibrosis in a patient with lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:1131-4. PMID:<br />

22495876<br />

218. Canas CA, Rincon-Hoyos HG, Izquierdo JH, Bonilla-Abadia F, Arbelaez-Cortes A.<br />

Psychiatric manifestations in patients with dysau<strong>to</strong>nomy associated with systemic lupus<br />

erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:1128-30. PMID: 22460293<br />

219. Piotrowski P, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP. Contribution of<br />

STAT4 gene single-nucleotide polymorphism <strong>to</strong> systemic lupus erythema<strong>to</strong>sus in the Polish<br />

population. Mol Biol Rep <strong>2012</strong>;39:8861-6. PMID: 22729903<br />

220. Anders HJ, Appel GB. <strong>Lupus</strong> nephritis: Implications of the new ACR lupus nephritis<br />

guidelines. Nat Rev Nephrol <strong>2012</strong>;8:500-1. PMID: 22825673<br />

221. Gregersen JW, Jayne DR. B-cell depletion in the treatment of lupus nephritis. Nat Rev<br />

Nephrol <strong>2012</strong>;8:505-14. PMID: 22801948<br />

222. Yang XW, Tan Y, Yu F, Zhao MH. Combination of anti-C1q and anti-dsDNA antibodies is<br />

associated with higher renal disease activity and predicts renal prognosis of patients with lupus<br />

nephritis. Nephrol Dial Transplant <strong>2012</strong>;27:3552-9. PMID: 22700716<br />

223. Okpechi IG, Ayodele OE, Jones ES, Duffield M, Swanepoel CR. Outcome of patients with<br />

membranous lupus nephritis in Cape Town South Africa. Nephrol Dial Transplant<br />

<strong>2012</strong>;27:3509-15. PMID: 22610989<br />

224. El-Ansary M, Saadi G, Abd El-Hamid SM. Mesenchymal stem cells are a rescue approach<br />

for recovery of deteriorating kidney function. Nephrology (Carl<strong>to</strong>n) <strong>2012</strong>;17:650-7. PMID:<br />

22640266<br />

225. Nalcacioglu H, Genc G, Meydan BC, Ozkaya O. Hyperkalaemia in a female patient with<br />

systemic lupus erythema<strong>to</strong>sus. Pediatr Nephrol <strong>2012</strong>;27:1499-503. PMID: 22083362


226. Rodriguez-Hurtado FJ, Saez-Moreno JA, Rodriguez-Ferrer JM. Maculopathy in patient with<br />

systemic lupus erythema<strong>to</strong>sus treated with hydroxychloroquine. Reuma<strong>to</strong>l Clin <strong>2012</strong>;8:280-3.<br />

PMID: 22481059<br />

227. Minz RW, Kumar Y, Anand S, Singh S, Bamberi P, Verma S ,et al. Antinuclear antibody<br />

positive au<strong>to</strong>immune disorders in North India: an appraisal. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2883-8.<br />

PMID: 21898056<br />

228. Moez P, Soliman E. Association of PTPN22 gene polymorphism and systemic lupus<br />

erythema<strong>to</strong>sus in a cohort of Egyptian patients: impact on clinical and labora<strong>to</strong>ry results.<br />

Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2753-8. PMID: 21818561<br />

229. Yang Z, Liang Y, Li C, Xi W, Zhong R. Associations of serum urea, creatinine and uric<br />

acid with clinical and labora<strong>to</strong>ry features in patients with systemic lupus erythema<strong>to</strong>sus.<br />

Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2715-23. PMID: 21800118<br />

230. Dong J, Li H, Wang JB, Yao Y, Yang QR. Predic<strong>to</strong>rs for neuropsychiatric development in<br />

Chinese adolescents with systemic lupus erythema<strong>to</strong>sus. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2681-6. PMID:<br />

21789612<br />

231. Pisetsky DS. Antinuclear antibodies in rheumatic disease: a proposal for a function-based<br />

classification. Scand J Immunol <strong>2012</strong>;76:223-8. PMID: 22670594<br />

232. Fuentes L, Hernandez D, Ruiz P, Blanca L, Lopez V, Sola E ,et al. Survival of lupus<br />

nephritis patients after renal transplantation in Malaga. Transplant Proc <strong>2012</strong>;44:2067-8. PMID:<br />

22974911<br />

233. Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH. Predic<strong>to</strong>rs of end-stage renal<br />

disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.<br />

Clin Exp Rheuma<strong>to</strong>l <strong>2012</strong>; PMID: 22935632<br />

234. Tanzer M, Tran C, Messer KL, Kroeker A, Herreshoff E, Wickman L ,et al. Inpatient<br />

healthcare utilization by children and adolescents with systemic lupus erythema<strong>to</strong>sus and kidney<br />

involvement. Arthritis Care Res (Hoboken) <strong>2012</strong>; PMID: 22899662<br />

235. Chowdhary VR, Tilahun AY, Clark CR, Grande JP, Rajagopalan G. Chronic exposure <strong>to</strong><br />

staphylococcal superantigen elicits a systemic inflamma<strong>to</strong>ry disease mimicking lupus. J<br />

Immunol <strong>2012</strong>;189:2054-62. PMID: 22798666<br />

236. Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC ,et al. Urine levels of<br />

HMGB1 in Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus patients with and without renal manifestations.<br />

Arthritis Res Ther <strong>2012</strong>;14:R184. PMID: 22892043<br />

237. Clatworthy MR, Kettunen MI, Hu DE, Mathews RJ, Witney TH, Kennedy BW ,et al.<br />

Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early<br />

renal acute tubular necrosis. Proc Natl Acad Sci U S A <strong>2012</strong>;109:13374-9. PMID: 22837393


238. Mohanasundaram K, Rajasekaran K, Selvaraj J, Balasubramanian A. Successful treatment<br />

of Strongyloides stercoralis hyperinfection in a case of systemic lupus erythema<strong>to</strong>sus - review of<br />

the literature regarding various treatment schedules. Trop Doct <strong>2012</strong>; PMID: 22875806<br />

239. Ross S, Benz K, Sauerstein K, Amann K, Dotsch J, Dittrich K. Unexpected recovery from<br />

longterm renal failure in severe diffuse proliferative lupus nephritis. BMC Nephrol <strong>2012</strong>;13:81.<br />

PMID: 22867270<br />

240. Sinha A, Puri K, Hari P, Dinda AK, Bagga A. Etiology and Outcome of Crescentic<br />

Glomerulonephritis. Indian Pediatr <strong>2012</strong>; PMID: 23024099<br />

241. Hu SW, Myskowski PL, Papadopoulos EB, Busam KJ. Chronic cutaneous graft-versus-host<br />

disease simulating hypertrophic lupus erythema<strong>to</strong>sus--a case report of a new morphologic variant<br />

of graft-versus-host disease. Am J Derma<strong>to</strong>pathol <strong>2012</strong>;34:e81-e83. PMID: 22307231<br />

242. Hiraki LT, Feldman CH, Liu J, Alarcon GS, Fischer MA, Winkelmayer WC ,et al.<br />

Prevalence, incidence, and demographics of systemic lupus erythema<strong>to</strong>sus and lupus nephritis<br />

from 2000 <strong>to</strong> 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum<br />

<strong>2012</strong>;64:2669-76. PMID: 22847366<br />

243. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR ,et al. Derivation and<br />

validation of the Systemic <strong>Lupus</strong> International Collaborating Clinics classification criteria for<br />

systemic lupus erythema<strong>to</strong>sus. Arthritis Rheum <strong>2012</strong>;64:2677-86. PMID: 22553077<br />

244. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN ,et al. Association of<br />

noninvasively measured renal protein biomarkers with his<strong>to</strong>logic features of lupus nephritis.<br />

Arthritis Rheum <strong>2012</strong>;64:2687-97. PMID: 22328173<br />

245. Wang GB, Xu ZJ, Liu HF, Zhou QG, Zhou ZM, Jia N. Changes in pathological pattern and<br />

treatment regimens based on repeat renal biopsy in lupus nephritis. Chin Med J (Engl)<br />

<strong>2012</strong>;125:2890-4. PMID: 22932086<br />

246. Yokoyama H, Taguchi T, Sugiyama H, Sa<strong>to</strong> H. Membranous nephropathy in Japan:<br />

analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol <strong>2012</strong>;16:557-63. PMID:<br />

22358611<br />

247. Chang YS. Hypersensitivity reactions <strong>to</strong> pro<strong>to</strong>n pump inhibi<strong>to</strong>rs. Curr Opin Allergy Clin<br />

Immunol <strong>2012</strong>;12:348-53. PMID: 22744268<br />

248. Marder W, McCune WJ, Wang L, Wing JJ, Fisseha S, McConnell DS ,et al. Adjunctive<br />

GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide<br />

therapy in premenopausal SLE patients. Gynecol Endocrinol <strong>2012</strong>;28:624-7. PMID: 22296584<br />

249. Sinha A, Tiwari AN, Chanchlani R, Seetharamanjaneyulu V, Hari P, Bagga A. Therapeutic<br />

plasmapheresis using membrane plasma separation. Indian J Pediatr <strong>2012</strong>;79:1084-6. PMID:<br />

22766901


250. Gupta A, Biyani M, Robertson SJ. Renal cocktail: <strong>to</strong>o hard for a diabetic. Int Urol Nephrol<br />

<strong>2012</strong>;44:1289-92. PMID: 21785838<br />

251. Altit G, Brochu P, Jacob SV, Buithieu M. LE cells in pleural fluid. J Clin Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;18:273-4. PMID: 22832304<br />

252. Tonooka K, I<strong>to</strong> H, Shibata T, Ozaki S. Recombinant human soluble thrombomodulin for<br />

treatment of thrombotic microangiopathy associated with lupus nephritis. J Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;39:1766-7. PMID: 22859540<br />

253. Wang IK, Muo CH, Chang YC, Liang CC, Lin SY, Chang CT ,et al. Risks, subtypes, and<br />

hospitalization costs of stroke among patients with systemic lupus erythema<strong>to</strong>sus: a retrospective<br />

cohort study in Taiwan. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:1611-8. PMID: 22753653<br />

254. Gosev I, Mick SL, Couper GS, Shekar PS. Pulsatile biventricular assist device and an<br />

absent mitral valve. J Thorac Cardiovasc Surg <strong>2012</strong>;144:e23-e25. PMID: 22813918<br />

255. Wang S, Li X, Qu L, Wang R, Chen Y, Li Q ,et al. Tacrolimus versus cyclophosphamide as<br />

treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective<br />

cohort study. <strong>Lupus</strong> <strong>2012</strong>;21:1025-35. PMID: 22570338<br />

256. Shinar Y, Kosach E, Langevitz P, Zandman-Goddard G, Pauzner R, Rabinovich E ,et al.<br />

Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus<br />

erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:993-8. PMID: 22532615<br />

257. Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH ,et al.<br />

Recep<strong>to</strong>r for advanced glycation end products (RAGE) polymorphisms are associated with<br />

systemic lupus erythema<strong>to</strong>sus and disease severity in lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:959-68.<br />

PMID: 22513366<br />

258. Dhir V. Is cellular C4d a good biomarker for SLE nephritis? <strong>Lupus</strong> <strong>2012</strong>;21:1036. PMID:<br />

22472701<br />

259. Sa<strong>to</strong> VA, Marques ID, Goldenstein PT, Carmo LP, Jorge LB, Titan SM ,et al. <strong>Lupus</strong><br />

nephritis is more severe in children and adolescents than in older adults. <strong>Lupus</strong> <strong>2012</strong>;21:978-83.<br />

PMID: 22451604<br />

260. Okpechi IG, Swanepoel CR, Tiffin N, Duffield M, Rayner BL. Clinicopathological insights<br />

in<strong>to</strong> lupus nephritis in South Africans: a study of 251 patients. <strong>Lupus</strong> <strong>2012</strong>;21:1017-24. PMID:<br />

22451603<br />

261. Chen W, Liu Q, Chen W, Tang X, Fu P, Liu F ,et al. Outcomes of maintenance therapy with<br />

tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial.<br />

<strong>Lupus</strong> <strong>2012</strong>;21:944-52. PMID: 22438027


262. Henes M, Henes JC, Neunhoeffer E, Von WM, Schmalzing M, Kotter I ,et al. Fertility<br />

preservation methods in young women with systemic lupus erythema<strong>to</strong>sus prior <strong>to</strong> cy<strong>to</strong><strong>to</strong>xic<br />

therapy: experiences from the FertiPROTEKT network. <strong>Lupus</strong> <strong>2012</strong>;21:953-8. PMID: 22438026<br />

263. Maeshima K, Ishii K, Torigoe M, Imada C, Iwakura M, Hamasaki H ,et al. Successful<br />

<strong>to</strong>cilizumab and tacrolimus treatment in a patient with rheuma<strong>to</strong>id arthritis complicated by<br />

systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:1003-6. PMID: 22433919<br />

264. Rajadhyaksha A, Mehra S. Dengue fever evolving in<strong>to</strong> systemic lupus erythema<strong>to</strong>sus and<br />

lupus nephritis: a case report. <strong>Lupus</strong> <strong>2012</strong>;21:999-1002. PMID: 22354536<br />

265. Boursier G, Siri A, de BH. [Use of regula<strong>to</strong>ry T cells in cellular therapies in au<strong>to</strong>immune<br />

diseases]. Med Sci (Paris) <strong>2012</strong>;28:757-63. PMID: 22920878<br />

266. Tesar V, Hruskova Z. Recent news in the treatment of lupus nephritis. Minerva Med<br />

<strong>2012</strong>;103:235-51. PMID: 22805617<br />

267. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality<br />

in patients with lupus nephritis. Nephrol Dial Transplant <strong>2012</strong>;27:3248-54. PMID: 22523116<br />

268. Pession A, Zama D, Masetti R, Gasperini P, Prete A. Hema<strong>to</strong>poietic stem cell<br />

transplantation for curing children with severe au<strong>to</strong>immune diseases: is this a valid option?<br />

Pediatr Transplant <strong>2012</strong>;16:413-25. PMID: 22519456<br />

269. Lee SG, Cho YM, So MW, Kim SS, Kim YG, Lee CK ,et al. ISN/RPS 2003 class II<br />

mesangial proliferative lupus nephritis: a comparison between cases that progressed <strong>to</strong> class III<br />

or IV and cases that did not. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2459-64. PMID: 21769491<br />

270. Julkunen H, Ekblom-Kullberg S, Miettinen A. Nonrenal and renal activity of systemic lupus<br />

erythema<strong>to</strong>sus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3<br />

and C4. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2445-51. PMID: 21706294<br />

271. Yang Z, Liang Y, Li C, Xi W, Zhong R. Bilirubin levels in patients with systemic lupus<br />

erythema<strong>to</strong>sus: increased or decreased? Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2423-30. PMID: 21691742<br />

272. Martinez-Martinez MU, Borjas-Garcia JA, Magana-Aquino M, Cuevas-Orta E, Llamazares-<br />

Azuara L, Abud-Mendoza C. Renal function assessment in patients with systemic lupus<br />

erythema<strong>to</strong>sus. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2293-9. PMID: 21604063<br />

273. San<strong>to</strong>s MJ, Carmona-Fernandes D, Caetano-Lopes J, Perpetuo IP, Vidal B, Capela S ,et al.<br />

TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with<br />

systemic lupus erythema<strong>to</strong>sus. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2239-44. PMID: 21544635<br />

274. Canaud G, Audard V, Kofman T, Lang P, Legendre C, Grimbert P. Recurrence from<br />

primary and secondary glomerulopathy after renal transplant. Transpl Int <strong>2012</strong>;25:812-24.<br />

PMID: 22507183


275. Pei HY, Zhang Y, Fu SX, Yang L, Zhang LP. [Clinical and his<strong>to</strong>-pathological<br />

characteristics of 2874 cases with chronic kidney diseases in Southern parts of Hebei province].<br />

Zhonghua Liu Xing Bing Xue Za Zhi <strong>2012</strong>;33:850-3. PMID: 22967343<br />

276. Liu LL, Jiang Y, Wang LN, Yao L, Li ZL. Efficacy and safety of mycophenolate mofetil<br />

versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of<br />

randomized controlled trials. Drugs <strong>2012</strong>;72:1521-33. PMID: 22818016<br />

277. Olsen NJ, Li QZ, Quan J, Wang L, Mutwally A, Karp DR. Au<strong>to</strong>antibody profiling <strong>to</strong> follow<br />

evolution of lupus syndromes. Arthritis Res Ther <strong>2012</strong>;14:R174. PMID: 22838636<br />

278. Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W ,et al.<br />

Cross-species transcriptional network analysis defines shared inflamma<strong>to</strong>ry responses in murine<br />

and human lupus nephritis. J Immunol <strong>2012</strong>;189:988-1001. PMID: 22723521<br />

279. Singh S, Wu T, Xie C, Vanarsa K, Han J, Mahajan T ,et al. Urine VCAM-1 as a marker of<br />

renal pathology activity index in lupus nephritis. Arthritis Res Ther <strong>2012</strong>;14:R164. PMID:<br />

22788914<br />

280. Zakiyanov O, Kalousova M, Kra<strong>to</strong>chvilova M, Kriha V, Zima T, Tesar V. Changes in levels<br />

of matrix metalloproteinase-2 and -9, pregnancy-associated plasma protein-A in patients with<br />

various nephropathies. J Nephrol <strong>2012</strong>;0. PMID: 22760877<br />

281. Sandhu A, Alameel T, Dale CH, Levstik M, Chande N. The safety and efficacy of<br />

antitumour necrosis fac<strong>to</strong>r-alpha therapy for inflamma<strong>to</strong>ry bowel disease in patients post liver<br />

transplantation: a case series. Aliment Pharmacol Ther <strong>2012</strong>;36:159-65. PMID: 22616981<br />

282. Chan TM. Recent progress in the treatment of proliferative lupus nephritis. Am J Med<br />

<strong>2012</strong>;125:642-8. PMID: 22608789<br />

283. Kalra A, Yokogawa N, Raja H, Palaniswamy C, Desai P, Zanotti-Cavazzoni SL ,et al.<br />

Hydralazine-induced pulmonary-renal syndrome: a case report. Am J Ther <strong>2012</strong>;19:e136-e138.<br />

PMID: 20724911<br />

284. Carrillo-Cordova JR, Amezcua-Guerra LM. Au<strong>to</strong>immunity as a possible predisposing fac<strong>to</strong>r<br />

for Stenotrophomonas mal<strong>to</strong>philia endocarditis. Arch Cardiol Mex <strong>2012</strong>;82:204-7. PMID:<br />

23021356<br />

285. Watson L, Leone V, Pilking<strong>to</strong>n C, Tullus K, Rangaraj S, McDonagh JE ,et al. Disease<br />

activity, severity, and damage in the UK Juvenile-Onset Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus Cohort.<br />

Arthritis Rheum <strong>2012</strong>;64:2356-65. PMID: 22294381<br />

286. Ding Y, He J, Guo JP, Dai YJ, Li C, Feng M ,et al. Gender differences are associated with<br />

the clinical features of systemic lupus erythema<strong>to</strong>sus. Chin Med J (Engl) <strong>2012</strong>;125:2477-81.<br />

PMID: 22882925


287. Triplett TA, Curti BD, Bonafede PR, Miller WL, Walker EB, Weinberg AD. Defining a<br />

functionally distinct subset of human memory CD4+ T cells that are CD25POS and<br />

FOXP3NEG. Eur J Immunol <strong>2012</strong>;42:1893-905. PMID: 22585674<br />

288. Kattah AG, Fervenza FC. Rituximab: emerging treatment strategies of immune-mediated<br />

glomerular disease. Expert Rev Clin Immunol <strong>2012</strong>;8:413-21. PMID: 22882216<br />

289. Wang S, Adrian<strong>to</strong> I, Wiley GB, Lessard CJ, Kelly JA, Adler AJ ,et al. A functional<br />

haplotype of UBE2L3 confers risk for systemic lupus erythema<strong>to</strong>sus. Genes Immun<br />

<strong>2012</strong>;13:380-7. PMID: 22476155<br />

290. Mathai SC, Hassoun PM. Pulmonary arterial hypertension in connective tissue diseases.<br />

Heart Fail Clin <strong>2012</strong>;8:413-25. PMID: 22748903<br />

291. Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D. Anti-C1q<br />

au<strong>to</strong>antibodies specific against the globular domain of the C1qB-chain from patient with lupus<br />

nephritis inhibit C1q binding <strong>to</strong> IgG and CRP. Immunobiology <strong>2012</strong>;217:684-91. PMID:<br />

22209113<br />

292. Fadili W, Bassit NH, Ghali ZE, Laouad I. Unusual association of a positive pANCA pauciimmune<br />

extracapillary glomerulonephritis in a lupus patient. Indian J Nephrol <strong>2012</strong>;22:320-1.<br />

PMID: 23162284<br />

293. Aatif T, Maoujoud O, Montasser DI, Benyahia M, Oualim Z. Glomerular diseases in the<br />

Military Hospital of Morocco: Review of a single centre renal biopsy database on adults. Indian J<br />

Nephrol <strong>2012</strong>;22:257-63. PMID: 23162268<br />

294. Sou<strong>to</strong> MI, Coelho A, Guo C, Mendonca LM, Pinheiro MF, Papi JA ,et al. The prevalence of<br />

low bone mineral density in Brazilian patients with systemic lupus erythema<strong>to</strong>sus and its<br />

relationship with the disease damage index and other associated fac<strong>to</strong>rs. J Clin Densi<strong>to</strong>m<br />

<strong>2012</strong>;15:320-7. PMID: 22321657<br />

295. Seo JY, Byun HJ, Cho KH, Lee EB. Methimazole-induced bullous systemic lupus<br />

erythema<strong>to</strong>sus: a case report. J Korean Med Sci <strong>2012</strong>;27:818-21. PMID: 22787382<br />

296. Bramham K, Lights<strong>to</strong>ne L. Pre-pregnancy counseling for women with chronic kidney<br />

disease. J Nephrol <strong>2012</strong>;25:450-9. PMID: 22641575<br />

297. El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA. Angiopoietin-2, endothelial<br />

dysfunction and renal involvement in patients with systemic lupus erythema<strong>to</strong>sus. J Nephrol<br />

<strong>2012</strong>;25:541-50. PMID: 21956768<br />

298. Jallouli M, Saadoun D, Eymard B, Leroux G, Haroche J, Le Thi HD ,et al. The association<br />

of systemic lupus erythema<strong>to</strong>sus and myasthenia gravis: a series of 17 cases, with a special focus<br />

on hydroxychloroquine use and a review of the literature. J Neurol <strong>2012</strong>;259:1290-7. PMID:<br />

22160434


299. Duarte-Garcia A, Fang H, To CH, Magder LS, Petri M. Seasonal variation in the activity of<br />

systemic lupus erythema<strong>to</strong>sus. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:1392-8. PMID: 22660806<br />

300. Palazzo E, Yahia SA. Progressive multifocal leukoencephalopathy in au<strong>to</strong>immune diseases.<br />

Joint Bone Spine <strong>2012</strong>;79:351-5. PMID: 22281228<br />

301. Dhir V. Biomarker for interstitial inflammation. Kidney Int <strong>2012</strong>;82:243-4. PMID:<br />

22743570<br />

302. Kawasaki A, Furukawa H, Kondo Y, I<strong>to</strong> S, Hayashi T, Kusaoi M ,et al. Association of<br />

PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythema<strong>to</strong>sus<br />

in a Japanese population. <strong>Lupus</strong> <strong>2012</strong>;21:890-5. PMID: 22433914<br />

303. Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafstrom I ,et al.<br />

Microcirculation as determined by ion<strong>to</strong>phoresis in SLE-patients and controls. <strong>Lupus</strong><br />

<strong>2012</strong>;21:815-20. PMID: 22415927<br />

304. Chen TK, Estrella MM, Fine DM. Predic<strong>to</strong>rs of kidney biopsy complication among patients<br />

with systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:848-54. PMID: 22415926<br />

305. Law ST, Ma KM, Li KK. The clinical characteristics of lupus related protein-losing<br />

enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital.<br />

<strong>Lupus</strong> <strong>2012</strong>;21:840-7. PMID: 22343095<br />

306. Matar HE, Peterson P, Sangle S, D'Cruz DP. Correlation of 24-hour urinary protein<br />

quantification with spot urine protein:creatinine ratio in lupus nephritis. <strong>Lupus</strong> <strong>2012</strong>;21:836-9.<br />

PMID: 22331194<br />

307. Lopez-Lopez L, Gonzalez A, Vila LM. Long-term membranous glomerulonephritis as the<br />

presenting manifestation of systemic lupus erythema<strong>to</strong>sus in a patient with human<br />

immunodeficiency virus infection. <strong>Lupus</strong> <strong>2012</strong>;21:900-4. PMID: 22249649<br />

308. Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y ,et al. The microRNA miR-23b suppresses<br />

IL-17-associated au<strong>to</strong>immune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med<br />

<strong>2012</strong>;18:1077-86. PMID: 22660635<br />

309. Pham PT, Pham PC. The impact of mycophenolate mofetil versus azathioprine as<br />

adjunctive therapy <strong>to</strong> cyclosporine on the rates of renal allograft loss due <strong>to</strong> glomerular disease<br />

recurrence. Nephrol Dial Transplant <strong>2012</strong>;27:2965-71. PMID: 22207327<br />

310. Korbet SM, Lewis EJ. Complete remission in severe lupus nephritis: assessing the rate of<br />

loss in proteinuria. Nephrol Dial Transplant <strong>2012</strong>;27:2813-9. PMID: 22199359<br />

311. Skare TL, Godoi AL, Ferreira VO. Jaccoud arthropathy in systemic lupus erythema<strong>to</strong>sus:<br />

clinical and serological findings. Rev Assoc Med Bras <strong>2012</strong>;58:489-92. PMID: 22930030


312. Li WX, Pan HF, Chen GP, Tao JH, Li XP, Ye DQ. Expression of inducible co-stimula<strong>to</strong>r on<br />

peripheral blood T lymphocytes in patients with lupus nephritis. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:2051-5.<br />

PMID: 21479882<br />

313. Al-Mayouf S, Abdwani R, Al-Brawi S. Familial juvenile systemic lupus erythema<strong>to</strong>sus in<br />

Arab children. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:1939-43. PMID: 21461717<br />

314. Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J ,et al. Outcome of reclassification of<br />

World Health Organization (WHO) class III under International Society of Nephrology-Renal<br />

Pathology Society (ISN-RPS) classification: retrospective observational study. Rheuma<strong>to</strong>l Int<br />

<strong>2012</strong>;32:1877-84. PMID: 21442173<br />

315. Pons-Estel GJ, Alarcon GS, Hachuel L, Boggio G, Wojdyla D, Pascual-Ramos V ,et al.<br />

Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing<br />

SLE renal disease: data from a Latin-American cohort. Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>;51:1293-8.<br />

PMID: 22389125<br />

316. Gluhovschi G, Trandafirescu V, Solovan C, Lazar E, Gluhovschi C, Petrica L ,et al. Has the<br />

diversity of clinical and biological manifestations of systemic lupus erythema<strong>to</strong>sus a<br />

correspondent in the diversity of immune mechanisms? Observations based on a Rowell's<br />

syndrome case associated with arthritis and nephritis. Rom J Intern Med <strong>2012</strong>;50:249-55. PMID:<br />

23330294<br />

317. Habib MA, Badruddoza SM. Pattern of glomerular diseases among adults in Rajshahi, the<br />

Northern Region of Bangladesh. Saudi J Kidney Dis Transpl <strong>2012</strong>;23:876-80. PMID: 22805414<br />

318. Nandi M, Mondal R. Renal involvement in childhood lupus: a study from Kolkata, India.<br />

Saudi J Kidney Dis Transpl <strong>2012</strong>;23:871-5. PMID: 22805413<br />

319. Ibrahim S, Fayed A, Fadda S, Belal D. A five-year analysis of the incidence of<br />

glomerulonephritis at Cairo University Hospital-Egypt. Saudi J Kidney Dis Transpl<br />

<strong>2012</strong>;23:866-70. PMID: 22805412<br />

320. Herraiz I, Escribano D, Gomez-Arriaga PI, Hernindez-Garcia JM, Herraiz MA, Galindo A.<br />

Predictive value of sequential models of uterine artery Doppler in pregnancies at high risk for<br />

pre-eclampsia. Ultrasound Obstet Gynecol <strong>2012</strong>;40:68-74. PMID: 22102516<br />

321. Rios Blanco JJ, Martin SN, Alvarez PJ, Barbado Hernandez FJ. [Anti-neutrophil<br />

cy<strong>to</strong>plasmic antibodies: beyond vasculitis]. Med Clin (Barc) <strong>2012</strong>;139:137-8. PMID: 22245469<br />

322. Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V,<br />

Avihingsanon Y. Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-alpha2-<br />

glycoprotein, as a biomarker for active lupus nephritis. J Proteomics <strong>2012</strong>;75:3240-7. PMID:<br />

22498882


323. Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D ,et al. Semaphorin 3A is a<br />

marker for disease activity and a potential immunoregula<strong>to</strong>r in systemic lupus erythema<strong>to</strong>sus.<br />

Arthritis Res Ther <strong>2012</strong>;14:R146. PMID: 22697500<br />

324. Yuan J, Gou SJ, Huang J, Hao J, Chen M, Zhao MH. C5a and its recep<strong>to</strong>rs in human antineutrophil<br />

cy<strong>to</strong>plasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther<br />

<strong>2012</strong>;14:R140. PMID: 22691190<br />

325. Arends S, Grootscholten C, Derksen RH, Berger SP, de Sevaux RG, Voskuyl AE ,et al.<br />

Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus<br />

cyclophosphamide in patients with proliferative lupus nephritis. Ann Rheum Dis <strong>2012</strong>;71:966-<br />

73. PMID: 22128082<br />

326. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD ,et al.<br />

American College of Rheuma<strong>to</strong>logy guidelines for screening, treatment, and management of<br />

lupus nephritis. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:797-808. PMID: 22556106<br />

327. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES ,et al.<br />

Au<strong>to</strong>antibodies in lupus: culprits or passive bystanders? Au<strong>to</strong>immun Rev <strong>2012</strong>;11:596-603.<br />

PMID: 22041579<br />

328. Oudah N, Al DZ, Alsaad K, Qurashi S, Ghamdi G, Flaiw A ,et al. Glomerulonephritis with<br />

crescents among adult Saudi patients outcome and its predic<strong>to</strong>rs. Clin Exp Med <strong>2012</strong>;12:121-5.<br />

PMID: 21706346<br />

329. Iwazu Y, Akimo<strong>to</strong> T, Izawa S, Inoue M, Mu<strong>to</strong> S, Ando Y ,et al. Accelerated recovery from<br />

nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with<br />

lupus podocy<strong>to</strong>pathy. Clin Exp Nephrol <strong>2012</strong>;16:485-9. PMID: 22350466<br />

330. Haas M. Collapsing glomerulopathy in systemic lupus erythema<strong>to</strong>sus: an extreme form of<br />

lupus podocy<strong>to</strong>pathy? Clin J Am Soc Nephrol <strong>2012</strong>;7:878-80. PMID: 22554717<br />

331. Salva<strong>to</strong>re SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.<br />

Collapsing glomerulopathy in 19 patients with systemic lupus erythema<strong>to</strong>sus or lupus-like<br />

disease. Clin J Am Soc Nephrol <strong>2012</strong>;7:914-25. PMID: 22461531<br />

332. Mat<strong>to</strong>s P, Santiago MB. Disease activity in systemic lupus erythema<strong>to</strong>sus patients with endstage<br />

renal disease: systematic review of the literature. Clin Rheuma<strong>to</strong>l <strong>2012</strong>;31:897-905. PMID:<br />

22415467<br />

333. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, Pascual CY, Aller MA, Arias J ,et<br />

al. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr<br />

Mol Med <strong>2012</strong>;12:574-91. PMID: 22515979<br />

334. Zhi-Chun L, Qiao-Ling Z, Zhi-Qin L, Xiao-Zhao L, Xiao-xia Z, Rong T. Tumor necrosis<br />

fac<strong>to</strong>r-like weak inducer of apop<strong>to</strong>sis (TWEAK) mediates p38 mi<strong>to</strong>gen-activated protein kinase


activation and signal transduction in peripheral blood mononuclear cells from patients with lupus<br />

nephritis. Inflammation <strong>2012</strong>;35:935-43. PMID: 22009442<br />

335. Paul LJ, Cohen PR, Kurzrock R. Eyelash trichomegaly: review of congenital, acquired, and<br />

drug-associated etiologies for elongation of the eyelashes. Int J Derma<strong>to</strong>l <strong>2012</strong>;51:631-46.<br />

PMID: 22607279<br />

336. Rizk A, Gheita TA, Nassef S, Abdallah A. The impact of obesity in systemic lupus<br />

erythema<strong>to</strong>sus on disease parameters, quality of life, functional capacity and the risk of<br />

atherosclerosis. Int J Rheum Dis <strong>2012</strong>;15:261-7. PMID: 22212605<br />

337. de Araujo AA, Caramori JC, Vannini FD, Zanati SG, Barretti P, Matsubara BB ,et al.<br />

Markers of uremia and pericardial effusion in peri<strong>to</strong>neal dialysis. Int Urol Nephrol <strong>2012</strong>;44:923-<br />

7. PMID: 21853247<br />

338. Ramachandran R, Sakhuja V, Jha V, Kohli HS, Rathi M. Plasmapheresis in systemic lupus<br />

erythema<strong>to</strong>sus with thrombotic microangiopathy. Intern Med J <strong>2012</strong>;42:734. PMID: 22697162<br />

339. Feng X, Hao J, Liu Q, Yang L, Lv X, Zhang Y ,et al. HMGB1 mediates IFN-gammainduced<br />

cell proliferation in MMC cells through regulation of cyclin D1/CDK4/p16 pathway. J<br />

Cell Biochem <strong>2012</strong>;113:2009-19. PMID: 22275109<br />

340. Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tonshoff B, Haffner D ,et al. Activity of<br />

childhood lupus nephritis is linked <strong>to</strong> altered T cell and cy<strong>to</strong>kine homeostasis. J Clin Immunol<br />

<strong>2012</strong>;32:477-87. PMID: 22228566<br />

341. Mai TV, Tse K, Gehr MK, George J, Baranski J, Xavier M. Bilateral nephrec<strong>to</strong>my for the<br />

treatment of refrac<strong>to</strong>ry lupus nephritis with features overlapping with thrombotic<br />

microangiopathy resembling thrombotic thrombocy<strong>to</strong>penia purpura. J Clin Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;18:185-8. PMID: 22647858<br />

342. Shahane A, Khasnis A, Gota C. Rituximab-responsive nephrotic syndrome due <strong>to</strong> minimal<br />

change disease in systemic lupus erythema<strong>to</strong>sus. J Clin Rheuma<strong>to</strong>l <strong>2012</strong>;18:199-202. PMID:<br />

22647855<br />

343. Herrera FA, Lee CK, Kryger G, Roostaeian J, Safa B, Lohman RF ,et al. Microsurgery in<br />

the hypercoagulable patient: review of the literature. J Reconstr Microsurg <strong>2012</strong>;28:305-12.<br />

PMID: 22547257<br />

344. Kiani AN, Wu T, Fang H, Zhou XJ, Ahn CW, Magder LS ,et al. Urinary vascular cell<br />

adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus<br />

nephritis. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:1231-7. PMID: 22505707<br />

345. Yoshio T, Okamo<strong>to</strong> H, Onishi S, Minota S. Antiribosomal-P protein antibodies are<br />

associated with proliferative glomerulonephritis more strongly than with membranous


glomerulonephritis in Japanese patients with systemic lupus erythema<strong>to</strong>sus. Mod Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;22:488-90. PMID: 22042098<br />

346. Mora DJ, da Cunha Colombo ER, Ferreira-Paim K, Andrade-Silva LE, Nascentes GA,<br />

Silva-Vergara ML. Clinical, epidemiological and outcome features of patients with<br />

cryp<strong>to</strong>coccosis in Uberaba, Minas Gerais, Brazil. Mycopathologia <strong>2012</strong>;173:321-7. PMID:<br />

22130645<br />

347. Yang H, Xu A, Lv J, Liu Y. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr<br />

mice]. Nan Fang Yi Ke Da Xue Xue Bao <strong>2012</strong>;32:821-5. PMID: 22699062<br />

348. Huerta A, Bomback AS, Liakopoulos V, Palanisamy A, S<strong>to</strong>kes MB, D'Agati VD ,et al.<br />

Renal-limited 'lupus-like' nephritis. Nephrol Dial Transplant <strong>2012</strong>;27:2337-42. PMID: 22207326<br />

349. Purswani MU, Chernoff MC, Mitchell CD, Seage GR, III, Zilleruelo G, Abitbol C ,et al.<br />

Chronic kidney disease associated with perinatal HIV infection in children and adolescents.<br />

Pediatr Nephrol <strong>2012</strong>;27:981-9. PMID: 22366874<br />

350. Genevieve M, Bonnet F, Michaux C, Geffroy CE, Vandenhende MA, Combe C ,et al.<br />

[<strong>Lupus</strong> nephritis associated with common variable immunodeficiency: favourable outcome with<br />

intravenous immunoglobulin treatment]. Rev Med Interne <strong>2012</strong>;33:e31-e33. PMID: 22560369<br />

351. Gao JJ, Cai GY, Liu SW, Tang L, Zhang XG, Yang Y ,et al. Characteristics and influence<br />

fac<strong>to</strong>rs of pathologic transformation in the subclasses of class IV lupus nephritis. Rheuma<strong>to</strong>l Int<br />

<strong>2012</strong>;32:1751-9. PMID: 21442167<br />

352. Chen YQ, Xue Q, Wang NS. Visceral muscle dysmotility syndrome in systemic lupus<br />

erythema<strong>to</strong>sus: case report and review of the literature. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:1701-3. PMID:<br />

21431943<br />

353. Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of<br />

systemic lupus erythema<strong>to</strong>sus: meta-analysis and meta-regression of observational studies from<br />

the 1950s <strong>to</strong> 2000s. Semin Arthritis Rheum <strong>2012</strong>;41:830-9. PMID: 22257558<br />

354. Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL. Measurement of<br />

au<strong>to</strong>antibodies in pediatric-onset systemic lupus erythema<strong>to</strong>sus and their relationship with<br />

disease-associated manifestations. Semin Arthritis Rheum <strong>2012</strong>;41:840-8. PMID: 22177108<br />

355. Liu SY, Guo JY, Zhang L, Liu ZS, Zheng ZH, Cheng GY ,et al. [Incidence of metabolic<br />

syndrome in systemic lupus erythema<strong>to</strong>sus and its influence by glucocorticoids]. Zhonghua Nei<br />

Ke Za Zhi <strong>2012</strong>;51:441-4. PMID: 22943753<br />

356. Fujita K, Akasaka Y, Kuwabara T, Wang B, Tanaka K, Kamata I ,et al. Pathogenesis of<br />

lupus-like nephritis through au<strong>to</strong>immune antibody produced by CD180-negative B lymphocytes<br />

in NZBWF1 mouse. Immunol Lett <strong>2012</strong>;144:1-6. PMID: 22387632


357. Ferenkeh-Koroma A. Systemic lupus erythema<strong>to</strong>sus: nurse and patient education. Nurs<br />

Stand <strong>2012</strong>;26:49-57. PMID: 22787993<br />

358. Gonzalo E, Toldos O, Martinez-Vidal MP, Ordonez MC, Santiago B, Fernandez-Nebro A<br />

,et al. Clinicopathologic correlations of renal microthrombosis and inflamma<strong>to</strong>ry markers in<br />

proliferative lupus nephritis. Arthritis Res Ther <strong>2012</strong>;14:R126. PMID: 22640796<br />

359. Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm <strong>to</strong><br />

predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open<br />

cohort study. BMJ <strong>2012</strong>;344:e3427. PMID: 22619194<br />

360. Hanasand M, Omdal R, Norheim KB, Goransson LG, Brede C, Jonsson G. Improved<br />

detection of advanced oxidation protein products in plasma. Clin Chim Acta <strong>2012</strong>;413:901-6.<br />

PMID: 22336637<br />

361. Redondo-Pachon MD, Enriquez R, Sirvent AE, Andrada E, Millan I, Amoros F. Minimalchange<br />

nephropathy in systemic lupus erythema<strong>to</strong>sus. Nefrologia <strong>2012</strong>;32:412-3. PMID:<br />

22592436<br />

362. Chiang LL, Lin YT, Chan HY, Chiang BL. Differential manifestations of prepubescent,<br />

pubescent and postpubescent pediatric patients with systemic lupus erythema<strong>to</strong>sus: A<br />

retrospective study of 96 Chinese children and adolescents. Pediatr Rheuma<strong>to</strong>l Online J<br />

<strong>2012</strong>;10:12. PMID: 22551316<br />

363. Paliga A, Shahbazi N, Gonsalves C, Bormanis J, Padmore R. Trilineage myelodysplasia and<br />

hemophagocy<strong>to</strong>sis associated with systemic lupus erythema<strong>to</strong>sus. Am J Hema<strong>to</strong>l <strong>2012</strong>;87:529-<br />

30. PMID: 22038620<br />

364. Quaio CR, Carvalho JF, da Silva CA, Bueno C, Brasil AS, Pereira AC ,et al. Au<strong>to</strong>immune<br />

disease and multiple au<strong>to</strong>antibodies in 42 patients with RASopathies. Am J Med Genet A<br />

<strong>2012</strong>;158A:1077-82. PMID: 22488759<br />

365. Brinkman WT, Herbert MA, Prince SL, Ryan C, Ryan WH. Redo au<strong>to</strong>graft operations after<br />

the Ross procedure. Ann Thorac Surg <strong>2012</strong>;93:1477-81. PMID: 22464553<br />

366. El Khayat SS, Medkouri G, E<strong>to</strong>mba AM, Zamd M, Gharbi MB, Ramadani B. Thrombotic<br />

thrombocy<strong>to</strong>penic purpura and systemic lupus erythema<strong>to</strong>sus: a rare and life-threatening<br />

association. Arab J Nephrol Transplant <strong>2012</strong>;5:103-5. PMID: 22612197<br />

367. Soeiro AM, Bergamin FS, de Almeida MC, Serrano CV, Jr., Falcao BA, Ganem F. Rare<br />

manifestation of acute pulmonary edema associated with acute lupus myocarditis. Arq Bras<br />

Cardiol <strong>2012</strong>;98:e78-e81. PMID: 22858658<br />

368. Mina R, Klein-Gitelman MS, Ravelli A, Beresford MW, Avcin T, Espada G ,et al. Inactive<br />

disease and remission in childhood-onset systemic lupus erythema<strong>to</strong>sus. Arthritis Care Res<br />

(Hoboken) <strong>2012</strong>;64:683-93. PMID: 22238253


369. Dhir V, Aggarwal A, Lawrence A, Agarwal V, Misra R. Long-term outcome of lupus<br />

nephritis in Asian Indians. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:713-20. PMID: 22232126<br />

370. Santiago-Casas Y, Vila LM, McGwin G, Jr., Can<strong>to</strong>r RS, Petri M, Ramsey-Goldman R ,et al.<br />

Association of discoid lupus erythema<strong>to</strong>sus with clinical manifestations and damage accrual in a<br />

multiethnic lupus cohort. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:704-12. PMID: 22190480<br />

371. Bengtsson AA, Sturfelt G, Lood C, Ronnblom L, van Vollenhoven RF, Axelsson B ,et al.<br />

Pharmacokinetics, <strong>to</strong>lerability, and preliminary efficacy of paquinimod (ABR-215757), a new<br />

quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized,<br />

double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus<br />

erythema<strong>to</strong>sus. Arthritis Rheum <strong>2012</strong>;64:1579-88. PMID: 22131101<br />

372. Winchester R, Wiesendanger M, Zhang HZ, Steshenko V, Peterson K, Geraldino-Pardilla L<br />

,et al. Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell<br />

beta-chain clonotypes in progressive lupus nephritis. Arthritis Rheum <strong>2012</strong>;64:1589-600. PMID:<br />

22130908<br />

373. Shimp SK, III, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL ,et al. Heat<br />

shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of<br />

systemic lupus erythema<strong>to</strong>sus. Cell Mol Immunol <strong>2012</strong>;9:255-66. PMID: 22543833<br />

374. Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G ,et al. Evaluation of clinical<br />

outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol<br />

<strong>2012</strong>;7:757-64. PMID: 22442181<br />

375. Kallash M, Straatmann C, Craver RD, Aviles D. Nephrotic syndrome in an African<br />

American female. Clin Pediatr (Phila) <strong>2012</strong>;51:515-7. PMID: 22500045<br />

376. Shi D, Wang D, Li X, Zhang H, Che N, Lu Z ,et al. Allogeneic transplantation of umbilical<br />

cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus<br />

erythema<strong>to</strong>sus. Clin Rheuma<strong>to</strong>l <strong>2012</strong>;31:841-6. PMID: 22302582<br />

377. Saavedra MA, Cruz-Reyes C, Vera-Lastra O, Romero GT, Cruz-Cruz P, Arias-Flores R ,et<br />

al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin<br />

Rheuma<strong>to</strong>l <strong>2012</strong>;31:813-9. PMID: 22278163<br />

378. Swart JF, Lindemans CA, van RA, Boelens JJ, Prakken BJ, Wulffraat N. Changing winds in<br />

refrac<strong>to</strong>ry au<strong>to</strong>immune disease in children: clearing the road for <strong>to</strong>lerance with cellular therapies.<br />

Curr Opin Rheuma<strong>to</strong>l <strong>2012</strong>;24:267-73. PMID: 22418744<br />

379. Efe C, Wahlin S, Ozaslan E, Berlot AH, Purnak T, Mura<strong>to</strong>ri L ,et al. Au<strong>to</strong>immune<br />

hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic au<strong>to</strong>immune<br />

diseases. Eur J Gastroenterol Hepa<strong>to</strong>l <strong>2012</strong>;24:531-4. PMID: 22465972


380. Magistroni R. [Monoclonal antibodies in nephrology: a delicate balance between curative<br />

potential, evidence of effectiveness, and <strong>to</strong>xicity]. G Ital Nefrol <strong>2012</strong>;29:283-91. PMID:<br />

22718451<br />

381. Cravedi P. [Role of monoclonal antibodies in the treatment of immune-mediated kidney<br />

disease: the state of the art]. G Ital Nefrol <strong>2012</strong>;29:274-82. PMID: 22718450<br />

382. Xi J, Zhang GP, Qiao SL, Guo JQ, Wang XN, Yang YY ,et al. Increased survival and<br />

reduced renal injury in MRL/lpr mice treated with a human Fcgamma recep<strong>to</strong>r II (CD32)<br />

peptide. Immunology <strong>2012</strong>;136:46-53. PMID: 22236212<br />

383. Mandal SN, Jha R, Fatima R, Swarnalata G. Non-nephronal hematuria misdiagnosed as C1q<br />

nephropathy: Look before you leap. Indian J Nephrol <strong>2012</strong>;22:206-9. PMID: 23087557<br />

384. Monfared A, Khosravi M, Lebadi M, Mosavian Roshan Zamir SA, Hoda S, Habibzadeh SM<br />

,et al. Distribution of renal his<strong>to</strong>pathology in Guilan: a single-center report. Iran J Kidney Dis<br />

<strong>2012</strong>;6:173-7. PMID: 22555479<br />

385. Rogers MA, Levine DA, Blumberg N, Fisher GG, Kabe<strong>to</strong> M, Langa KM. Antigenic<br />

challenge in the etiology of au<strong>to</strong>immune disease in women. J Au<strong>to</strong>immun <strong>2012</strong>;38:J97-J102.<br />

PMID: 21880464<br />

386. Aftab W, Mlo<strong>to</strong>wsky J, Varadarajan P, Pai RG. Dobutamine stress-induced stroke in a<br />

patient with mechanical mitral prosthesis despite normal function. J Heart Valve Dis<br />

<strong>2012</strong>;21:407-9. PMID: 22808850<br />

387. Wang Z, Li M, Zeng X, Liu X. Hepatitis B virus-associated antigen deposition in renal<br />

tissue from patients with systemic lupus erythema<strong>to</strong>sus. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:974-8. PMID:<br />

22422490<br />

388. Jallouli M, Frigui M, Marzouk S, Snoussi M, Kechaou M, Kaddour N ,et al. Clinical<br />

implications and prognostic significance of thrombocy<strong>to</strong>penia in Tunisian patients with systemic<br />

lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:682-7. PMID: 22354537<br />

389. Cheng Q, Hoi A, Hickey MJ, Morand EF. Lymphocytes from systemic lupus erythema<strong>to</strong>sus<br />

patients display increased spreading on VCAM-1, an effect associated with active renal<br />

involvement. <strong>Lupus</strong> <strong>2012</strong>;21:632-41. PMID: 22345121<br />

390. Wu FX, Luo XY, Wu LJ, Yang MH, Long L, Liu NT ,et al. Association of chemokine<br />

CXCL12-3'G801A polymorphism with systemic lupus erythema<strong>to</strong>sus in a Han Chinese<br />

population. <strong>Lupus</strong> <strong>2012</strong>;21:604-10. PMID: 22311941<br />

391. Piccoli GB, Attini R, Vigotti FN, Naret<strong>to</strong> C, Fassio F, Randone O ,et al. NEMO syndrome<br />

(incontinentia pigmenti) and systemic lupus erythema<strong>to</strong>sus: a new disease association. <strong>Lupus</strong><br />

<strong>2012</strong>;21:675-81. PMID: 22235006


392. Kher A, Kher V. Immunotherapy in renal diseases. Med Clin North Am <strong>2012</strong>;96:545-64, x.<br />

PMID: 22703855<br />

393. de Moraes-Vasconcelos D, Domingues-Ferreira M, de Campos PP, da Silva Duarte AJ.<br />

Chronic mucocutaneous candidiasis and systemic lupus erythema<strong>to</strong>sus: a new variant of chronic<br />

mucocutaneous candidiasis? Med Mycol <strong>2012</strong>;50:399-403. PMID: 21988702<br />

394. Sa<strong>to</strong>skar AA, Shapiro JP, Bott CN, Song H, Nadasdy GM, Brodsky SV ,et al.<br />

Characterization of glomerular diseases using proteomic analysis of laser capture microdissected<br />

glomeruli. Mod Pathol <strong>2012</strong>;25:709-21. PMID: 22282304<br />

395. S<strong>to</strong>enoiu MS, Aydin S, Tek<strong>to</strong>nidou M, Ravelingien I, le G, V, Fiehn C ,et al. Repeat kidney<br />

biopsies fail <strong>to</strong> detect differences between azathioprine and mycophenolate mofetil maintenance<br />

therapy for lupus nephritis: data from the MAINTAIN <strong>Nephritis</strong> Trial. Nephrol Dial Transplant<br />

<strong>2012</strong>;27:1924-30. PMID: 22110048<br />

396. Omokawa A, Komatsuda A, Nara M, Fujiwara S, Sa<strong>to</strong> R, Togashi M ,et al. Distribution of<br />

glomerular IgG subclass deposits in patients with membranous nephropathy and anti-U1<br />

ribonucleoprotein antibody. Nephrol Dial Transplant <strong>2012</strong>;27:1937-41. PMID: 21968014<br />

397. Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW ,et al. Pilot 24 month study <strong>to</strong> compare<br />

mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with<br />

nephrotic syndrome. Nephrology (Carl<strong>to</strong>n) <strong>2012</strong>;17:352-7. PMID: 22295934<br />

398. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM ,et al. Glomerular and<br />

tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology<br />

(Carl<strong>to</strong>n) <strong>2012</strong>;17:346-51. PMID: 22295894<br />

399. van TA, Voskuyl AE, Vervloet MG, Bijl M, de Sevaux RG, Berger SP ,et al. Dutch<br />

guidelines for diagnosis and therapy of proliferative lupus nephritis. Neth J Med <strong>2012</strong>;70:199-<br />

207. PMID: 22641632<br />

400. Radhakrishna SM, Reiff AO, Marzan KA, Azen C, Khemani RG, Rubin S ,et al. Pediatric<br />

rheumatic disease in the intensive care unit: lessons learned from 15 years of experience in a<br />

tertiary care pediatric hospital. Pediatr Crit Care Med <strong>2012</strong>;13:e181-e186. PMID: 22561277<br />

401. Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tonshoff B, Haffner D ,et al. Soluble<br />

VEGF recep<strong>to</strong>r 1 promotes endothelial injury in children and adolescents with lupus nephritis.<br />

Pediatr Nephrol <strong>2012</strong>;27:793-800. PMID: 22147121<br />

402. Brugos B, Vincze Z, Sipka S, Szegedi G, Zeher M. Serum and urinary cy<strong>to</strong>kine levels of<br />

SLE patients. Pharmazie <strong>2012</strong>;67:411-3. PMID: 22764573<br />

403. Liu Y, La CA. Targeting BLyS in systemic lupus erythema<strong>to</strong>sus. Recent Pat Inflamm<br />

Allergy Drug Discov <strong>2012</strong>;6:91-6. PMID: 22216778


404. Martinez-Martinez MU, Abud-Mendoza C. Serum cystatin C as a marker of renal function<br />

in patients with systemic lupus erythema<strong>to</strong>sus. Reuma<strong>to</strong>l Clin <strong>2012</strong>;8:158-9. PMID: 22483659<br />

405. Arce-Salinas CA, Rodriguez-Garcia F, Gomez-Vargas JI. Long-term efficacy of anti-CD20<br />

antibodies in refrac<strong>to</strong>ry lupus nephritis. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:1245-9. PMID: 21258801<br />

406. Rabbani MA, Memon GM, Ahmad B, Memon S, Tahir SA, Tahir S. Percutaneous renal<br />

biopsy results: a retrospective analysis of 511 consecutive cases. Saudi J Kidney Dis Transpl<br />

<strong>2012</strong>;23:614-8. PMID: 22569458<br />

407. Kadikoy H, Haque W, Hoang V, Maliakkal J, Nisbet J, Abdellatif A. Posterior reversible<br />

encephalopathy syndrome in a patient with lupus nephritis. Saudi J Kidney Dis Transpl<br />

<strong>2012</strong>;23:572-6. PMID: 22569448<br />

408. Nakagiri T, Inoue M, Minami M, Shintani Y, Okumura M. Immunology mini-review: the<br />

basics of T(H)17 and interleukin-6 in transplantation. Transplant Proc <strong>2012</strong>;44:1035-40. PMID:<br />

22564619<br />

409. Ma C, Wei J, Zhan F, Wang R, Fu K, Wan X ,et al. Urinary hypoxia-inducible fac<strong>to</strong>r-<br />

1alpha levels are associated with his<strong>to</strong>logic chronicity changes and renal function in patients<br />

with lupus nephritis. Yonsei Med J <strong>2012</strong>;53:587-92. PMID: 22477004<br />

410. Nonaka K, Ubara Y, Suwabe T, Takaichi K, Oohashi K. Intractable membranous lupus<br />

nephritis showing selective improvement of subepithelial deposits with tacrolimus therapy: a<br />

case report. Clin Nephrol <strong>2012</strong>; PMID: 22541676<br />

411. Xu Y, Lee PY, Li Y, Liu C, Zhuang H, Han S ,et al. Pleiotropic IFN-dependent and -<br />

independent effects of IRF5 on the pathogenesis of experimental lupus. J Immunol<br />

<strong>2012</strong>;188:4113-21. PMID: 22422888<br />

412. Crispin JC, Apos<strong>to</strong>lidis SA, Rosetti F, Keszei M, Wang N, Terhorst C ,et al. Cutting edge:<br />

protein phosphatase 2A confers susceptibility <strong>to</strong> au<strong>to</strong>immune disease through an IL-17-<br />

dependent mechanism. J Immunol <strong>2012</strong>;188:3567-71. PMID: 22422882<br />

413. Kiremitci S, Calayoglu R, Ensari A, Erbay B. Pathologist's puzzle: Membranoproliferative<br />

glomerulonephritis-like features in cryoglobulinemic glomerulonephritis. Pathol Res Pract<br />

<strong>2012</strong>;208:254-8. PMID: 22381806<br />

414. Bataille S, Daumas A, Tasei AM, Jourde-Chiche N, Dussol B, Burtey S ,et al. Vancomycininduced<br />

Henoch-Schonlein purpura: a case report. J Med Case Rep <strong>2012</strong>;6:106. PMID:<br />

22490390<br />

415. Dijkstra D, Hennig C, Witte T, Hansen G. Basophils from humans with systemic lupus<br />

erythema<strong>to</strong>sus do not express MHC-II. Nat Med <strong>2012</strong>;18:488-9. PMID: 22481402


416. Peixo<strong>to</strong> D, Teixeira F, Costa JA, Costa L, Araujo D. Encefalopatia posterior reversivel: a<br />

importancia do seu reconhecimen<strong>to</strong> nos doentes com <strong>Lupus</strong> Eritema<strong>to</strong>so Sistemico. Acta<br />

Reuma<strong>to</strong>l Port <strong>2012</strong>;37:192-4. PMID: 23149644<br />

417. Fernandes H, Bri<strong>to</strong> I. Juvenile Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus: neuropsychiatric<br />

manifestations. Acta Reuma<strong>to</strong>l Port <strong>2012</strong>;37:117-25. PMID: 23149633<br />

418. Gunnarsson I, Schlumberger W, Ronnelid J. Antibodies <strong>to</strong> M-type phospholipase A2<br />

recep<strong>to</strong>r (PLA2R) and membranous lupus nephritis. Am J Kidney Dis <strong>2012</strong>;59:585-6. PMID:<br />

22177657<br />

419. Steiman AJ, Gladman DD, Ibanez D, Urowitz MB. Outcomes in patients with systemic<br />

lupus erythema<strong>to</strong>sus with and without a prolonged serologically active clinically quiescent<br />

period. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:511-8. PMID: 22162433<br />

420. Ma Y, Xu WD, Pan HF, Ye DQ. New evidence for the role of proteasome inhibi<strong>to</strong>rs in<br />

systemic lupus erythema<strong>to</strong>sus: comment on the article by Ichikawa et al. Arthritis Rheum<br />

<strong>2012</strong>;64:1302. PMID: 22294290<br />

421. Lights<strong>to</strong>ne L. The landscape after LUNAR: rituximab's crater-filled path. Arthritis Rheum<br />

<strong>2012</strong>;64:962-5. PMID: 22231618<br />

422. Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J ,et al. Efficacy<br />

and safety of rituximab in patients with active proliferative lupus nephritis: the <strong>Lupus</strong> <strong>Nephritis</strong><br />

Assessment with Rituximab study. Arthritis Rheum <strong>2012</strong>;64:1215-26. PMID: 22231479<br />

423. Hirose T, Kameda Y, Yoshikawa Y, Abe T, Hayata Y, Taniguchi S. Aortic root<br />

replacement for Valsalva sinus aneurysm with lupus erythema<strong>to</strong>sus. Asian Cardiovasc Thorac<br />

Ann <strong>2012</strong>;20:193-5. PMID: 22499970<br />

424. Uchida K, Nitta K. Recent advances in the treatment of lupus nephritis. Clin Exp Nephrol<br />

<strong>2012</strong>;16:202-13. PMID: 22057583<br />

425. Yu TM, Wen MC, Li CY, Cheng CH, Wu MJ, Chen CH ,et al. Impact of recurrent lupus<br />

nephritis on lupus kidney transplantation: a 20-year single center experience. Clin Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;31:705-10. PMID: 22215121<br />

426. Chiche L, Jourde N, Ulmann C, Mancini J, Darque A, Bardin N ,et al. Seasonal variations<br />

of systemic lupus erythema<strong>to</strong>sus flares in southern France. Eur J Intern Med <strong>2012</strong>;23:250-4.<br />

PMID: 22385883<br />

427. Tachaudomdach C, Kantachuvesiri S, Changsirikulchai S, Wimolluck S, Pinpradap K,<br />

Kitiyakara C. Connective tissue growth fac<strong>to</strong>r gene expression and decline in renal function in<br />

lupus nephritis. Exp Ther Med <strong>2012</strong>;3:713-8. PMID: 22969957


428. Lin CP, Adrian<strong>to</strong> I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM ,et al. Role of<br />

MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun<br />

<strong>2012</strong>;13:232-8. PMID: 22189356<br />

429. Tagoe C, Putterman C. JAK2 inhibition in murine systemic lupus erythema<strong>to</strong>sus.<br />

Immunotherapy <strong>2012</strong>;4:369-72. PMID: 22512630<br />

430. Liu ZC, Zhou QL. Tumor necrosis fac<strong>to</strong>r-like weak inducer of apop<strong>to</strong>sis and its potential<br />

roles in lupus nephritis. Inflamm Res <strong>2012</strong>;61:277-84. PMID: 22297307<br />

431. Punyawudho B, Lertdumrongluk P, Somparn P, Kittanamongkolchai W, Traitanon O,<br />

Avihingsanon Y ,et al. Population pharmacokinetics of mycophenolate mofetil in Thai lupus<br />

nephritis patients. Int J Clin Pharmacol Ther <strong>2012</strong>;50:272-80. PMID: 22456298<br />

432. Rodenas M, Kumar S, Freund KB, Moallem J. Retinitis preceding systemic lupus<br />

erythema<strong>to</strong>sus in absence of anti-phospholipid antibodies. Int J Rheum Dis <strong>2012</strong>;15:e28-e30.<br />

PMID: 22462431<br />

433. Keith MP, Pitchford C, Bernstein WB. Treatment of hemophagocytic lymphohistiocy<strong>to</strong>sis<br />

with alemtuzumab in systemic lupus erythema<strong>to</strong>sus. J Clin Rheuma<strong>to</strong>l <strong>2012</strong>;18:134-7. PMID:<br />

22426581<br />

434. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic<br />

lupus erythema<strong>to</strong>sus in a multiethnic population. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:759-69. PMID: 22382348<br />

435. Zhou TB, Liu YG, Lin N, Qin YH, Huang K, Shao MB ,et al. Relationship between<br />

angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus<br />

erythema<strong>to</strong>sus/lupus nephritis: a systematic review and metaanalysis. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:686-<br />

93. PMID: 22337243<br />

436. Frankovich JD, Hsu JJ, Sandborg CI. European ancestry decreases the risk of early onset,<br />

severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort. <strong>Lupus</strong><br />

<strong>2012</strong>;21:421-9. PMID: 22427363<br />

437. Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in<br />

women with lupus nephritis: a review of published evidence. <strong>Lupus</strong> <strong>2012</strong>;21:534-41. PMID:<br />

22311940<br />

438. Kim JM, Kwok SK, Ju JH, Kim HY, Park SH. Idiopathic intracranial hypertension as a<br />

significant cause of intractable headache in patients with systemic lupus erythema<strong>to</strong>sus: a 15-<br />

year experience. <strong>Lupus</strong> <strong>2012</strong>;21:542-7. PMID: 22300830<br />

439. Watson L, Midgley A, Pilking<strong>to</strong>n C, Tullus K, Marks S, Holt R ,et al. Urinary monocyte<br />

chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in<br />

juvenile-onset systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:496-501. PMID: 22147846


440. Oliveira CS, Oliveira I, Bacchiega AB, Klumb EM, Albuquerque EM, Souza E ,et al. Renal<br />

transplantation in lupus nephritis: a Brazilian cohort. <strong>Lupus</strong> <strong>2012</strong>;21:570-4. PMID: 22129601<br />

441. Chow SL, Chandran V, Fazelzad R, Johnson SR. Prognostic fac<strong>to</strong>rs for survival in systemic<br />

lupus erythema<strong>to</strong>sus associated pulmonary hypertension. <strong>Lupus</strong> <strong>2012</strong>;21:353-64. PMID:<br />

22127457<br />

442. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, McCauliffe D<br />

,et al. Vitamin D status in systemic lupus erythema<strong>to</strong>sus patients and its association with selected<br />

clinical and labora<strong>to</strong>ry parameters. <strong>Lupus</strong> <strong>2012</strong>;21:477-84. PMID: 22065093<br />

443. Mallett A, John GT, Ranganathan D, Kark A, Berquier I, Casey J ,et al. Sustained remission<br />

of systemic lupus erythema<strong>to</strong>sus related calciphylaxis. <strong>Lupus</strong> <strong>2012</strong>;21:441-4. PMID: 22031536<br />

444. Carneiro FO, Sampaio LR, Brandao LA, Braga LL, Rocha FA. Protein-losing enteropathy<br />

as initial manifestation of systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:445-8. PMID:<br />

21997967<br />

445. Hashimo<strong>to</strong> A, Endo H, Kondo H, Hirohata S. Clinical features of 405 Japanese patients<br />

with systemic sclerosis. Mod Rheuma<strong>to</strong>l <strong>2012</strong>;22:272-9. PMID: 21874591<br />

446. Kulkarni OP, Ryu M, Kantner C, Sardy M, Naylor D, Lambert D ,et al. Recombinant<br />

chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice. Nephrol<br />

Dial Transplant <strong>2012</strong>;27:1358-67. PMID: 21987536<br />

447. Alsuwaida A, Husain S, Alghonaim M, AlOudah N, Alwakeel J, ullah A ,et al. Strategy for<br />

second kidney biopsy in patients with lupus nephritis. Nephrol Dial Transplant <strong>2012</strong>;27:1472-8.<br />

PMID: 21931127<br />

448. Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y ,et al. Mycophenolate mofetil or tacrolimus<br />

compared with intravenous cyclophosphamide in the induction treatment for active lupus<br />

nephritis. Nephrol Dial Transplant <strong>2012</strong>;27:1467-72. PMID: 21917733<br />

449. Noda S, Ogura M, Tsutsumi A, Udagawa T, Kamei K, Matsuoka K ,et al. Thrombotic<br />

microangiopathy due <strong>to</strong> multiple au<strong>to</strong>antibodies related <strong>to</strong> antiphospholipid syndrome. Pediatr<br />

Nephrol <strong>2012</strong>;27:681-5. PMID: 22210384<br />

450. Tyndall A. Application of au<strong>to</strong>logous stem cell transplantation in various adult and pediatric<br />

rheumatic diseases. Pediatr Res <strong>2012</strong>;71:433-8. PMID: 22358068<br />

451. Costedoat-Chalumeau N, Arnaud L, Saadoun D, Chastre J, Leroux G, Cacoub P ,et al.<br />

[Catastrophic antiphospholipid syndrome]. Rev Med Interne <strong>2012</strong>;33:194-9. PMID: 22341856<br />

452. Xing Q, Wang B, Su H, Cui J, Li J. Elevated Th17 cells are accompanied by FoxP3+ Treg<br />

cells decrease in patients with lupus nephritis. Rheuma<strong>to</strong>l Int <strong>2012</strong>;32:949-58. PMID: 21243492


453. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in<br />

Chinese patients with systemic lupus erythema<strong>to</strong>sus: relationship with disease activity, vascular<br />

risk fac<strong>to</strong>rs and atherosclerosis. Rheuma<strong>to</strong>logy (Oxford) <strong>2012</strong>;51:644-52. PMID: 21719424<br />

454. Furst DE, Mandell B. Perspectives in Rheuma<strong>to</strong>id Abstracts from 2011 meeting selected<br />

proceedings of the 4(th) Annual Perspectives in Rheumatic Diseases 2011. Semin Arthritis<br />

Rheum <strong>2012</strong>;41:737-9. PMID: 22483654<br />

455. Moroni G, Quaglini S, Gravellone L, Gallelli B, Leoni A, Messa P ,et al. Membranous<br />

nephropathy in systemic lupus erythema<strong>to</strong>sus: long-term outcome and prognostic fac<strong>to</strong>rs of 103<br />

patients. Semin Arthritis Rheum <strong>2012</strong>;41:642-51. PMID: 22285127<br />

456. Xie CH, Wang YY, Li ZJ, Tang J, Li BQ. [Expression and clinical significance of PD-L1<br />

on CD14(+) monocyte in the peripheral blood of patients with systemic lupus erythema<strong>to</strong>sus]. Xi<br />

Bao Yu Fen Zi Mian Yi Xue Za Zhi <strong>2012</strong>;28:429-32. PMID: 22482418<br />

457. Wu XL, Sun WS, Shi XM, Wang Z, An P, Qiao CL. [Effect of artemisinin on the<br />

expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice].<br />

Zhong Yao Cai <strong>2012</strong>;35:608-12. PMID: 23019910<br />

458. Martinho AL, Capela A, Duarte F. [Hypokalemic paralysis: the first presentation of primary<br />

Sjogren's syndrome]. Acta Med Port <strong>2012</strong>;25:122-4. PMID: 22985924<br />

459. Kambham N. Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM<br />

diseases. Adv Anat Pathol <strong>2012</strong>;19:111-24. PMID: 22313839<br />

460. Vernon KA, Cook HT. Complement in glomerular disease. Adv Chronic Kidney Dis<br />

<strong>2012</strong>;19:84-92. PMID: 22449345<br />

461. Favier R, Kheyar T, Renolleau S, Tabone MD, Favier M, Ulinski T. [<strong>Lupus</strong> anticoagulanthypoprothrombinemia<br />

syndrome revealing systemic lupus in an 11-year old girl in a context of<br />

clinical and biological emergency]. Ann Biol Clin (Paris) <strong>2012</strong>;70:226-30. PMID: 22484537<br />

462. Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM ,et al. IRF5<br />

haplotypes demonstrate diverse serological associations which predict serum interferon alpha<br />

activity and explain the majority of the genetic association with systemic lupus erythema<strong>to</strong>sus.<br />

Ann Rheum Dis <strong>2012</strong>;71:463-8. PMID: 22088620<br />

463. Mina R, von SE, Ardoin SP, Eberhard BA, Punaro M, Ilowite N ,et al. Consensus treatment<br />

plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic<br />

lupus erythema<strong>to</strong>sus. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:375-83. PMID: 22162255<br />

464. Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA, Jr. ,et al.<br />

Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken)<br />

<strong>2012</strong>;64:358-67. PMID: 22052658


465. Diaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martinez-Berriotxoa A ,et al.<br />

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from<br />

European cohorts. Au<strong>to</strong>immun Rev <strong>2012</strong>;11:357-64. PMID: 22032879<br />

466. Aringer M, Smolen JS. Therapeutic blockade of TNF in patients with SLE-promising or<br />

crazy? Au<strong>to</strong>immun Rev <strong>2012</strong>;11:321-5. PMID: 21619949<br />

467. Vaideeswar P, Divate S, Harke M. Intracardiac thrombi in extracardiac disorders: an<br />

au<strong>to</strong>psy study. Cardiovasc Pathol <strong>2012</strong>;21:e1-e9. PMID: 22197050<br />

468. Gronwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman GJ. IgM au<strong>to</strong>antibodies<br />

<strong>to</strong> distinct apop<strong>to</strong>sis-associated antigens correlate with protection from cardiovascular events and<br />

renal disease in patients with SLE. Clin Immunol <strong>2012</strong>;142:390-8. PMID: 22297166<br />

469. Jourde-Chiche N, Daniel L, Chiche L, Burtey S, Mancini J, Jego S ,et al. Association<br />

between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis. Clin Nephrol<br />

<strong>2012</strong>;77:211-8. PMID: 22377252<br />

470. Chander S, Gordon P. Soft tissue and subcutaneous calcification in connective tissue<br />

diseases. Curr Opin Rheuma<strong>to</strong>l <strong>2012</strong>;24:158-64. PMID: 22227955<br />

471. Arnaud L, Mathian A, Boddaert J, Amoura Z. Late-onset systemic lupus erythema<strong>to</strong>sus:<br />

epidemiology, diagnosis and treatment. Drugs Aging <strong>2012</strong>;29:181-9. PMID: 22263748<br />

472. Lorenz HM. [Connective tissue diseases]. Dtsch Med Wochenschr <strong>2012</strong>;137:661-3. PMID:<br />

22434176<br />

473. Pin<strong>to</strong> VM. [<strong>Lupus</strong>, Graves' disease, and vasculitis: a case report]. Endocrinol Nutr<br />

<strong>2012</strong>;59:222-4. PMID: 22154895<br />

474. Aranda F, Wingeyer SP, Munoz SA, Allievi A, Orden A, Trobo R ,et al. The -2518 A/G<br />

polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of<br />

developing systemic lupus erythema<strong>to</strong>sus in Argentinean patients: a multicenter study. Eur<br />

Cy<strong>to</strong>kine Netw <strong>2012</strong>;23:7-11. PMID: 22466290<br />

475. Ueda T, E<strong>to</strong> H, Katsuoka K, Takeuchi Y. <strong>Lupus</strong> erythema<strong>to</strong>sus panniculitis treated with<br />

tacrolimus. Eur J Derma<strong>to</strong>l <strong>2012</strong>;22:260-1. PMID: 22407061<br />

476. Shen L, Lu G, Dong N, Jiang L, Ma Z, Ruan C. Von Willebrand fac<strong>to</strong>r, ADAMTS13<br />

activity, TNF-alpha and their relationships in patients with chronic kidney disease. Exp Ther<br />

Med <strong>2012</strong>;3:530-4. PMID: 22969924<br />

477. Ramachandran R, Sharma V, Rathi M, Yadav AK, Sharma A, Kohli HS ,et al. Association<br />

between -1486 T>C and +1174 G>A single nucleotide polymorphisms in TLR9 gene and<br />

severity of lupus nephritis. Indian J Nephrol <strong>2012</strong>;22:125-9. PMID: 22787315


478. Couser WG. Basic and translational concepts of immune-mediated glomerular diseases. J<br />

Am Soc Nephrol <strong>2012</strong>;23:381-99. PMID: 22282593<br />

479. Taniguchi T, Amoh Y, Tanabe K, Katsuoka K, Kuroyanagi Y. Treatment of intractable skin<br />

ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of<br />

eight cases. J Artif Organs <strong>2012</strong>;15:77-82. PMID: 21861088<br />

480. Solorzano GT, Silva MV, Moreira SR, Nishida SK, Kirsztajn GM. Urinary<br />

protein/creatinine ratio versus 24-hour proteinuria in the evaluation of lupus nephritis. J Bras<br />

Nefrol <strong>2012</strong>;34:64-7. PMID: 22441184<br />

481. Cho SB, Ahn KJ, Kim dH, Zheng Z, Cho S, Kang SW ,et al. Identification of HnRNP-<br />

A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behcet's disease. J Invest<br />

Derma<strong>to</strong>l <strong>2012</strong>;132:601-8. PMID: 22205302<br />

482. Kim YC, Lee H, Ryu HH, Beom SH, Yang Y, Kim S ,et al. Aspergillus-associated cerebral<br />

aneurysm successfully treated by endovascular and surgical intervention with voriconazole in<br />

lupus nephritis patient. J Korean Med Sci <strong>2012</strong>;27:317-20. PMID: 22379345<br />

483. Cui JH, Qiao Q, Guo Y, Zhang YQ, Cheng H, He FR ,et al. Increased apop<strong>to</strong>sis and<br />

expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV. J Nephrol<br />

<strong>2012</strong>;25:255-61. PMID: 21725926<br />

484. Nasir H, Chaudhry S, Raza W, Moatasim A, Mamoon N, Akhtar N. Role of<br />

immunoflourescence in the diagnosis of glomerulonephritis. J Pak Med Assoc <strong>2012</strong>;62:240-3.<br />

PMID: 22764456<br />

485. Abu-Shakra M, Novack V. Mortality and multiple causes of death in systemic lupus<br />

erythema<strong>to</strong>sus -- role of the death certificate. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:458-60. PMID: 22383351<br />

486. Izmirly PM, Shvartsbeyn M, Meehan S, Franks A, Braun A, Ginzler E ,et al. Dysregulation<br />

of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis. J<br />

Rheuma<strong>to</strong>l <strong>2012</strong>;39:510-5. PMID: 22298906<br />

487. Souza DC, San<strong>to</strong> AH, Sa<strong>to</strong> EI. Mortality profile related <strong>to</strong> systemic lupus erythema<strong>to</strong>sus: a<br />

multiple cause-of-death analysis. J Rheuma<strong>to</strong>l <strong>2012</strong>;39:496-503. PMID: 22247362<br />

488. Jin T, Almehed K, Carlsten H, Forsblad-d'Elia H. <strong>Dec</strong>reased serum levels of TGF-beta1 are<br />

associated with renal damage in female patients with systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong><br />

<strong>2012</strong>;21:310-8. PMID: 22072025<br />

489. Lertnawapan R, Bian A, Rho YH, Raggi P, Oeser A, Solus JF ,et al. Cystatin C is associated<br />

with inflammation but not atherosclerosis in systemic lupus erythema<strong>to</strong>sus. <strong>Lupus</strong> <strong>2012</strong>;21:279-<br />

87. PMID: 22072023


490. Aliaga LG, Barreira JC. Calciphylaxis in a patient with systemic lupus erythema<strong>to</strong>sus<br />

without renal insufficiency or hyperparathyroidism. <strong>Lupus</strong> <strong>2012</strong>;21:329-31. PMID: 21997968<br />

491. Ejaz AA, Asmar A, Alsabbagh MM, Ahsan N. Rituximab in immunologic glomerular<br />

diseases. MAbs <strong>2012</strong>;4: PMID: 22377738<br />

492. Opastirakul S, Chartapisak W. Pulse cyclophosphamide induction treatment in Thai<br />

children with diffuse proliferative lupus nephritis. Nephrology (Carl<strong>to</strong>n) <strong>2012</strong>;17:269-73. PMID:<br />

22181066<br />

493. Canaud G, Legendre C. [Kidney allograft: a target for systemic disease]. Presse Med<br />

<strong>2012</strong>;41:311-7. PMID: 22244721<br />

494. Karras A. [Renal involvement in systemic lupus erythema<strong>to</strong>sus]. Presse Med <strong>2012</strong>;41:260-<br />

6. PMID: 22192934<br />

495. Ruiz-Iras<strong>to</strong>rza G, Espinosa G, Jimenez-Alonso J, Pallares L, Robles A. [Diagnosis and<br />

treatment of lupus nephritis: the way <strong>to</strong> consensus]. Rev Clin Esp <strong>2012</strong>;212:155-6. PMID:<br />

22532984<br />

496. Ruiz-Iras<strong>to</strong>rza G, Espinosa G, Fru<strong>to</strong>s MA, Jimenez AJ, Praga M, Pallares L ,et al.<br />

[Diagnosis and treatment of lupus nephritis]. Rev Clin Esp <strong>2012</strong>;212:147-30. PMID: 22361331<br />

497. Biver-Dalle C, Gil H, Meaux-Ruault N, Mermet-Ginet I, Aubin F, Humbert P ,et al.<br />

[Acquired ichthyosis and livedoid palmoplantar kera<strong>to</strong>derma: two unusual skin manifestations of<br />

systemic lupus erythema<strong>to</strong>sus]. Rev Med Interne <strong>2012</strong>;33:e14-e16. PMID: 21429634<br />

498. Cohen C, Mekinian A, Rouvier P, Pham I, Fain O. [Antiphospholipid syndrome, systemic<br />

lupus erythema<strong>to</strong>sus: endocarditis and glomerulopathy]. Rev Prat <strong>2012</strong>;62:316. PMID:<br />

22514979<br />

499. Wu R, Li R. Propylthiouracil-induced au<strong>to</strong>immune syndromes: 11 case report. Rheuma<strong>to</strong>l<br />

Int <strong>2012</strong>;32:679-81. PMID: 21136260<br />

500. Lopez R, Davidson JE, Beeby MD, Egger PJ, Isenberg DA. <strong>Lupus</strong> disease activity and the<br />

risk of subsequent organ damage and mortality in a large lupus cohort. Rheuma<strong>to</strong>logy (Oxford)<br />

<strong>2012</strong>;51:491-8. PMID: 22109798<br />

501. Abdullah LS. His<strong>to</strong>pathological pattern of pediatric renal diseases: a study from a university<br />

hospital in western Saudi Arabia. Saudi J Kidney Dis Transpl <strong>2012</strong>;23:377-84. PMID: 22382245<br />

502. Gupta V, Sachdeva S, Khan AS, Haque SF. Diffuse proliferative crescentic lupus nephritis<br />

with normal renal function. Saudi J Kidney Dis Transpl <strong>2012</strong>;23:343-5. PMID: 22382232<br />

503. Kadikoy H, Haque W, Ahmed S, Abdellatif A. Rituximab in the treatment of refrac<strong>to</strong>ry<br />

lupus nephritis with vasculitis. Saudi J Kidney Dis Transpl <strong>2012</strong>;23:334-7. PMID: 22382230


504. Szodoray P, Varoczy L, Papp G, Barath S, Nakken B, Szegedi G ,et al. Immunological<br />

reconstitution after au<strong>to</strong>logous stem cell transplantation in patients with refrac<strong>to</strong>ry systemic<br />

au<strong>to</strong>immune diseases. Scand J Rheuma<strong>to</strong>l <strong>2012</strong>;41:110-5. PMID: 21936606<br />

505. Wang T, Zhao H, Yu L, Chen LJ, Fan XY, Xie CH ,et al. [The expression and clinical<br />

significance of IL-17AR on peripheral blood B cells of patients with systemic lupus<br />

erythema<strong>to</strong>sus]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi <strong>2012</strong>;28:301-3. PMID: 22394643<br />

506. Li GY, Liu SX, Lu XQ. [Effects of langchuangping granule on the expression of B<br />

lymphocyte activating fac<strong>to</strong>r in the peripheral blood B cells of BXSB lupus nephritis mice].<br />

Zhongguo Zhong Xi Yi Jie He Za Zhi <strong>2012</strong>;32:367-70. PMID: 22686085<br />

507. Cimaz R. Pediatric rheumatic disease: Treating lupus nephritis in children--is there a gold<br />

standard? Nat Rev Rheuma<strong>to</strong>l <strong>2012</strong>;8:192-3. PMID: 22370458<br />

508. Zickert A, Palmblad K, Sundelin B, Chavan S, Tracey KJ, Bruchfeld A ,et al. Renal<br />

expression and serum levels of high mobility group box 1 protein in lupus nephritis. Arthritis Res<br />

Ther <strong>2012</strong>;14:R36. PMID: 22348591<br />

509. Sze<strong>to</strong> CC, Tam LS, Kwan BC, Lai KB, Wang G, Li EK ,et al. Moni<strong>to</strong>ring of urinary<br />

messenger RNA levels for the prediction of flare in systemic lupus erythema<strong>to</strong>sus. Clin Chim<br />

Acta <strong>2012</strong>;413:448-55. PMID: 22120729<br />

510. I<strong>to</strong> K, Yamada K, Mizushima I, Aizu M, Fujii H, Mizu<strong>to</strong>mi K ,et al. Henoch-Schonlein<br />

purpura nephritis in a patient with IgG4-related disease: A possible association. Clin Nephrol<br />

<strong>2012</strong>; PMID: 22841022<br />

511. Reddy BY, Xu DS, Hantash BM. Mesenchymal stem cells as immunomodula<strong>to</strong>r therapies<br />

for immune-mediated systemic derma<strong>to</strong>ses. Stem Cells Dev <strong>2012</strong>;21:352-62. PMID: 21864110<br />

512. Arnaud L, Zahr N, Amoura Z. Mycophenolate or azathioprine maintenance in lupus<br />

nephritis. N Engl J Med <strong>2012</strong>;366:572. PMID: 22316460<br />

513. Chocair PR, Duley JA. Mycophenolate or azathioprine maintenance in lupus nephritis. N<br />

Engl J Med <strong>2012</strong>;366:572. PMID: 22316459<br />

514. Ginzler EM, Wax S, Rajeswaran A, Copt S, Hillson J, Ramos E ,et al. Atacicept in<br />

combination with MMF and corticosteroids in lupus nephritis: results of a prematurely<br />

terminated trial. Arthritis Res Ther <strong>2012</strong>;14:R33. PMID: 22325903<br />

515. Balow JE. Glomerular disease: perspectives on maintenance therapy in lupus nephritis. Nat<br />

Rev Nephrol <strong>2012</strong>;8:136-8. PMID: 22310950<br />

516. Soeiro AM, Almeida MC, Accorsi TA, Spina GS, Serrano CV, Jr., Tarasoutchi F.<br />

Association between immunological diseases and their similar clinical manifestations. Arq Bras<br />

Cardiol <strong>2012</strong>;98:e28-e31. PMID: 22378340


517. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of<br />

the epidemiology of systemic lupus erythema<strong>to</strong>sus in the Asia-Pacific region: prevalence,<br />

incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:159-68. PMID:<br />

22052624<br />

518. Yelin E, Tonner C, Trupin L, Gansky SA, Julian L, Katz P ,et al. Longitudinal study of the<br />

impact of incident organ manifestations and increased disease activity on work loss among<br />

persons with systemic lupus erythema<strong>to</strong>sus. Arthritis Care Res (Hoboken) <strong>2012</strong>;64:169-75.<br />

PMID: 22006458<br />

519. Ichikawa HT, Conley T, Muchamuel T, Jiang J, Lee S, Owen T ,et al. Beneficial effect of<br />

novel proteasome inhibi<strong>to</strong>rs in murine lupus via dual inhibition of type I interferon and<br />

au<strong>to</strong>antibody-secreting cells. Arthritis Rheum <strong>2012</strong>;64:493-503. PMID: 21905015<br />

520. Taraborelli M, Andreoli L, Tincani A. Much more than thrombosis and pregnancy loss: the<br />

antiphospholipid syndrome as a 'systemic disease'. Best Pract Res Clin Rheuma<strong>to</strong>l <strong>2012</strong>;26:79-<br />

90. PMID: 22424195<br />

521. Appel GB. New and future therapies for lupus nephritis. Cleve Clin J Med <strong>2012</strong>;79:134-40.<br />

PMID: 22301564<br />

522. Frieri M. Accelerated atherosclerosis in systemic lupus erythema<strong>to</strong>sus: role of<br />

proinflamma<strong>to</strong>ry cy<strong>to</strong>kines and therapeutic approaches. Curr Allergy Asthma Rep <strong>2012</strong>;12:25-<br />

32. PMID: 22113625<br />

523. Yang XW, Tan Y, Yu F, Zhao MH. Interference of antimodified C-reactive protein<br />

au<strong>to</strong>antibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Hum<br />

Immunol <strong>2012</strong>;73:156-63. PMID: 22192784<br />

524. Gluhovschi C, Velciov S, Kaycsa A, Gluhovschi G, Petrica L, Marian R ,et al. The<br />

dynamics of urinary N-acetyl-beta-D-glucosaminidase (NAG), a marker of renal tubular<br />

dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.<br />

Immunopharmacol Immuno<strong>to</strong>xicol <strong>2012</strong>;34:163-9. PMID: 21651460<br />

525. Lee YH, Lee HS, Choi SJ, Ji JD, Song GG. Associations between eNOS polymorphisms<br />

and susceptibility <strong>to</strong> systemic lupus erythema<strong>to</strong>sus: a meta-analysis. Inflamm Res <strong>2012</strong>;61:135-<br />

41. PMID: 22105628<br />

526. Howe HS, Kong KO, Thong BY, Law WG, Chia FL, Lian TY ,et al. Urine sVCAM-1 and<br />

sICAM-1 levels are elevated in lupus nephritis. Int J Rheum Dis <strong>2012</strong>;15:13-6. PMID: 22324942<br />

527. Shu E, Ichiki Y, Moriya C, Iwata H, Kitajima Y, Seishima M. Three siblings with systemic<br />

lupus erythema<strong>to</strong>sus. J Derma<strong>to</strong>l <strong>2012</strong>;39:164-7. PMID: 22132698<br />

528. Kobkitcharoen M, Teerapornlertratt T, Chawanasun<strong>to</strong>rapoj R, Chanchairujira T,<br />

Laowahutanont N, Parichatikanond P ,et al. Late onset lupus nephritis: analysis of clinical


manifestations and renal pathological features in Siriraj Hospital. J Med Assoc Thai <strong>2012</strong>;95<br />

Suppl 2:S213-S217. PMID: 22574552<br />

529. Zhang X, Nagaraja HN, Nadasdy T, Song H, McKinley A, Prosek J ,et al. A composite<br />

urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int<br />

<strong>2012</strong>;81:401-6. PMID: 21993584<br />

530. Bassi N, Luiset<strong>to</strong> R, Del PD, Ghirardello A, Ceol M, Rizzo S ,et al. Induction of the 'ASIA'<br />

syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). <strong>Lupus</strong><br />

<strong>2012</strong>;21:203-9. PMID: 22235054<br />

531. Soldevilla HF, Briones SF, Navarra SV. Systemic lupus erythema<strong>to</strong>sus following HPV<br />

immunization or infection? <strong>Lupus</strong> <strong>2012</strong>;21:158-61. PMID: 22235047<br />

532. Dell'era L, Boati E, Nebbia G, Corona F. Wilson's disease treated with penicillamine and<br />

lupus erythema<strong>to</strong>sus: related or distinct entities? Minerva Pediatr <strong>2012</strong>;64:55-7. PMID:<br />

22350045<br />

533. Shimizu C, Fujita T, Fuke Y, I<strong>to</strong> K, Sa<strong>to</strong>mura A, Matsumo<strong>to</strong> K ,et al. High circulating<br />

levels of interleukin-18 binding protein indicate the severity of glomerular involvement in<br />

systemic lupus erythema<strong>to</strong>sus. Mod Rheuma<strong>to</strong>l <strong>2012</strong>;22:73-9. PMID: 21656327<br />

534. Mitwalli AH, Hayat A, Alwakeel J, Hammad D. Effects of concomitant hepatitis C virus<br />

infection in patients with underlying lupus nephritis on long-term renal outcome. Nephrol Dial<br />

Transplant <strong>2012</strong>;27:627-32. PMID: 21771749<br />

535. Stummvoll GH, Schmaldienst S, Smolen JS, Derfler K, Biesenbach P. <strong>Lupus</strong> nephritis:<br />

prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.<br />

Nephrol Dial Transplant <strong>2012</strong>;27:618-26. PMID: 21617196<br />

536. Cohen MJ, Theodor I, Elazary AS, Bekerman P, Nahmias A, Rubinov A ,et al. Severe<br />

malnutrition due <strong>to</strong> systemic lupus erythema<strong>to</strong>sus associated protein losing enteropathy.<br />

Nutrition <strong>2012</strong>;28:220-3. PMID: 22208557<br />

537. Calzada AP, Balaker AE, Ishiyama G, Lopez IA, Ishiyama A. Temporal bone<br />

his<strong>to</strong>pathology and immunoglobulin deposition in Sjogren's syndrome. O<strong>to</strong>l Neuro<strong>to</strong>l<br />

<strong>2012</strong>;33:258-66. PMID: 22215450<br />

538. Yamada A, Ueda N. Age and gender may affect posterior reversible encephalopathy<br />

syndrome in renal disease. Pediatr Nephrol <strong>2012</strong>;27:277-83. PMID: 21822908<br />

539. Ananthanarayanan S, Gereige R, Al-Owain M, Nguyen L, Kansagra S, Shaw A ,et al. Index<br />

of suspicion. Case 1: Lymphadenopathy, prolonged hematuria, proteinuria, and weight loss in a<br />

teenage boy. Case 2: Red, Swollen, painful eye in a 12-year-old boy with methylmalonic<br />

acidemia. Case 3: P<strong>to</strong>sis and diplopia after a respira<strong>to</strong>ry infection in a 7-year-old girl. Pediatr<br />

Rev <strong>2012</strong>;33:89-94. PMID: 22301036


540. Weiss JE. Pediatric systemic lupus erythema<strong>to</strong>sus: more than a positive antinuclear<br />

antibody. Pediatr Rev <strong>2012</strong>;33:62-73. PMID: 22301032<br />

541. Yoshida H. [Clinicopathological study of chronic kidney diseases (CKD)]. Rinsho Byori<br />

<strong>2012</strong>;60:145-56. PMID: 22568096<br />

542. Cugler T, Carvalho LM, Facincani I, Yamamo<strong>to</strong> AY, Silva GE, Costa RS ,et al. Severe<br />

glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking<br />

systemic lupus erythema<strong>to</strong>sus. Scand J Rheuma<strong>to</strong>l <strong>2012</strong>;41:79-81. PMID: 22043904<br />

543. Uhlenhaut C, Cohen JI, Pavletic S, Illei G, Gea-Banacloche JC, Abu-Asab M ,et al. Use of a<br />

novel virus detection assay <strong>to</strong> identify coronavirus HKU1 in the lungs of a hema<strong>to</strong>poietic stem<br />

cell transplant recipient with fatal pneumonia. Transpl Infect Dis <strong>2012</strong>;14:79-85. PMID:<br />

21749586<br />

544. Feng ST, Gan HL, Sun JY, Jiang T, Liu BL, Zhao ZH ,et al. [Expression of neonatal Fc<br />

recep<strong>to</strong>r on human nephritis and rat nephritis models]. Zhonghua Bing Li Xue Za Zhi<br />

<strong>2012</strong>;41:81-5. PMID: 22455882<br />

545. Rivera F, Fulladosa X, Poveda R, Fru<strong>to</strong>s MA, Garcia-Frias P, Ara J ,et al. Mycophenolate<br />

as induction therapy in lupus nephritis with renal function impairment. Am J Nephrol<br />

<strong>2012</strong>;35:424-33. PMID: 22517244<br />

546. Bang SY, Lee CK, Kang YM, Kim HA, Suh CH, Chung WT ,et al. Multicenter<br />

retrospective analysis of the effectiveness and safety of rituximab in korean patients with<br />

refrac<strong>to</strong>ry systemic lupus erythema<strong>to</strong>sus. Au<strong>to</strong>immune Dis <strong>2012</strong>;<strong>2012</strong>:565039. PMID: 23304457<br />

547. Wenderfer SE, Thacker T. Intravenous immunoglobulin in the management of lupus<br />

nephritis. Au<strong>to</strong>immune Dis <strong>2012</strong>;<strong>2012</strong>:589359. PMID: 23056926<br />

548. Lu R, Robertson JM, Bruner BF, Guthridge JM, Neas BR, Nath SK ,et al. Multiple<br />

Au<strong>to</strong>antibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a<br />

Large, Ethnically Diverse SLE Patient Cohort. Au<strong>to</strong>immune Dis <strong>2012</strong>;<strong>2012</strong>:819634. PMID:<br />

22988489<br />

549. Yung S, Chan TM. The Role of Hyaluronan and CD44 in the Pathogenesis of <strong>Lupus</strong><br />

<strong>Nephritis</strong>. Au<strong>to</strong>immune Dis <strong>2012</strong>;<strong>2012</strong>:207190. PMID: 22900150<br />

550. de Zubiria SA, Herrera-Diaz C. <strong>Lupus</strong> nephritis: an overview of recent findings.<br />

Au<strong>to</strong>immune Dis <strong>2012</strong>;<strong>2012</strong>:849684. PMID: 22536486<br />

551. Kajiwara M, Ueno T, Fukuda N, Matsuda H, Shimokawa T, Kitai M ,et al. Development of<br />

pyrrole-imidazole polyamide targeting fc recep<strong>to</strong>r common gamma chain for the treatment of<br />

immune-complex related renal disease. Biol Pharm Bull <strong>2012</strong>;35:2028-35. PMID: 22971693


552. Nagasawa M, Aoki Y. A pediatric case of systemic lupus erythema<strong>to</strong>sus developed 10 years<br />

after cord blood transplantation for juvenile myelomonocytic leukemia. Case Rep Transplant<br />

<strong>2012</strong>;<strong>2012</strong>:619126. PMID: 23304620<br />

553. Varoczy L, Kiss E, Tarr T, Zeher M, Szegedi G, Illes A. Fatal CMV-Infection after<br />

Au<strong>to</strong>logous Stem Cell Transplantation in Refrac<strong>to</strong>ry Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus. Case Rep<br />

Transplant <strong>2012</strong>;<strong>2012</strong>:465089. PMID: 23259132<br />

554. Suzumori N, Obayashi S, Kumagai K, Go<strong>to</strong> S, Yoshida A, Sugiura-Ogasawara M. A Case<br />

of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the<br />

Literature. Case Report Med <strong>2012</strong>;<strong>2012</strong>:827543. PMID: 22811728<br />

555. Nishina N, Kaneko Y, Kuwana M, Hanaoka H, Kameda H, Mikami S ,et al. IgG4-Related<br />

Disease without Overexpression of IgG4: Pathogenesis Implications. Case Report Rheuma<strong>to</strong>l<br />

<strong>2012</strong>;<strong>2012</strong>:754935. PMID: 22937457<br />

556. Gu L, Xu L, Zhang X, Tan W, Wang H, Zhang M. Correlation of Circulating<br />

Glucocorticoid-Induced TNFR-Related Protein Ligand Levels with Disease Activity in Patients<br />

with Systemic <strong>Lupus</strong> Erythema<strong>to</strong>sus. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:265868. PMID: 23251213<br />

557. Teixeira PC, Cutler P, Vuilleumier N. Au<strong>to</strong>antibodies <strong>to</strong> apolipoprotein A-1 in<br />

cardiovascular diseases: current perspectives. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:868251. PMID:<br />

23227091<br />

558. Liu C, Wei Y, Wang J, Pi L, Huang J, Wang P. Carbonic anhydrases III and IV<br />

au<strong>to</strong>antibodies in rheuma<strong>to</strong>id arthritis, systemic lupus erythema<strong>to</strong>sus, diabetes, hypertensive<br />

renal disease, and heart failure. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:354594. PMID: 23049597<br />

559. Marmont du Haut Champ AM. Hema<strong>to</strong>poietic stem cell transplantation for systemic lupus<br />

erythema<strong>to</strong>sus. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:380391. PMID: 22969816<br />

560. Wang D, Akiyama K, Zhang H, Yamaza T, Li X, Feng X ,et al. Double allogenic<br />

mesenchymal stem cells transplantations could not enhance therapeutic effect compared with<br />

single transplantation in systemic lupus erythema<strong>to</strong>sus. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:273291.<br />

PMID: 22829849<br />

561. Shen Y, Sun CY, Wu FX, Chen Y, Dai M, Yan YC ,et al. Association of intrarenal B-cell<br />

infiltrates with clinical outcome in lupus nephritis: a study of 192 cases. Clin Dev Immunol<br />

<strong>2012</strong>;<strong>2012</strong>:967584. PMID: 22792121<br />

562. Yung S, Chan TM. Au<strong>to</strong>antibodies and resident renal cells in the pathogenesis of lupus<br />

nephritis: getting <strong>to</strong> know the unknown. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:139365. PMID:<br />

22761629


563. Jiang YW, Li H, Zhang YY, Li W, Jiang YF, Ou YY ,et al. Beneficial effect of Bupleurum<br />

polysaccharides on au<strong>to</strong>immune-prone MRL-lpr mice. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:842928.<br />

PMID: 22701502<br />

564. Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome<br />

of lupus and of lupus nephritis. Clin Dev Immunol <strong>2012</strong>;<strong>2012</strong>:604892. PMID: 22690240<br />

565. Yang Z, Liang Y, Li C, Zhong R. Serum CA125 elevation is independently associated with<br />

serositis in SLE patients. Clin Exp Rheuma<strong>to</strong>l <strong>2012</strong>;30:93-8. PMID: 22260844<br />

566. Gronwall C, Vas J, Silverman GJ. Protective Roles of Natural IgM Antibodies. Front<br />

Immunol <strong>2012</strong>;3:66. PMID: 22566947<br />

567. Bose N, Wang X, Gupta M, Yao Q. The clinical utility of anti-chromatin antibodies as<br />

measured by BioPlex 2200 in the diagnosis of systemic lupus erythema<strong>to</strong>sus versus other<br />

rheumatic diseases. Int J Clin Exp Med <strong>2012</strong>;5:316-20. PMID: 22993651<br />

568. Lech M, Susanti HE, Rommele C, Grobmayr R, Gunthner R, Anders HJ. Quantitative<br />

expression of C-type lectin recep<strong>to</strong>rs in humans and mice. Int J Mol Sci <strong>2012</strong>;13:10113-31.<br />

PMID: 22949850<br />

569. Kerschbaum J, Konig P, Rudnicki M. Risk fac<strong>to</strong>rs associated with peri<strong>to</strong>neal-dialysisrelated<br />

peri<strong>to</strong>nitis. Int J Nephrol <strong>2012</strong>;<strong>2012</strong>:483250. PMID: 23320172<br />

570. Mok CC. Understanding lupus nephritis: diagnosis, management, and treatment options. Int<br />

J Womens Health <strong>2012</strong>;4:213-22. PMID: 22675266<br />

571. Rajendiran A, Viswanathan S, Remalayam B, Muthu V, Alexander T. Chronic diarrhea as<br />

the presenting complaint of systemic lupus erythema<strong>to</strong>sus in a man. Intern Med <strong>2012</strong>;51:3131-4.<br />

PMID: 23154718<br />

572. Yahata M, Takahashi S, Nakaya I, Sakuma T, Sa<strong>to</strong> H, Soma J. Possible IgG4-related kidney<br />

disease requiring a differential diagnosis of membranous lupus nephritis. Intern Med<br />

<strong>2012</strong>;51:1731-6. PMID: 22790135<br />

573. Arai A, Imadome K, Wang L, Wu N, Kurosu T, Wake A ,et al. Recurrence of chronic active<br />

Epstein-Barr virus infection from donor cells after achieving complete response through<br />

allogeneic bone marrow transplantation. Intern Med <strong>2012</strong>;51:777-82. PMID: 22466838<br />

574. Xuejing Z, Jiazhen T, Jun L, Xiangqing X, Shuguang Y, Fuyou L. Urinary TWEAK level<br />

as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol <strong>2012</strong>;<strong>2012</strong>:359647.<br />

PMID: 22719208<br />

575. Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY ,et al. Urinary neutrophil gelatinaseassociated<br />

lipocalin is a potential biomarker for renal damage in patients with systemic lupus<br />

erythema<strong>to</strong>sus. J Biomed Biotechnol <strong>2012</strong>;<strong>2012</strong>:759313. PMID: 22500106


576. Kurna<strong>to</strong>wska I, Jedrzejka D, Malyska A, Wagrowska-Danilewicz M, Danilewicz M,<br />

Nowicki M. Trends in the incidence of biopsy-proven glomerular diseases in the adult population<br />

in Central Poland in the years 1990-2010. Kidney Blood Press Res <strong>2012</strong>;35:254-8. PMID:<br />

22327616<br />

577. Yuan Y, Kasar S, Underbayev C, Prakash S, Raveche E. MicroRNAs in Acute Myeloid<br />

Leukemia and Other Blood Disorders. Leuk Res Treatment <strong>2012</strong>;<strong>2012</strong>:603830. PMID:<br />

23259069<br />

578. Scindia Y, Nackiewicz D, Dey P, Szymula A, Bajwa A, Rosin DL ,et al. Activated CD4+ T<br />

Cells Target Mesangial Antigens and Initiate Glomerulonephritis. Nephron Exp Nephrol<br />

<strong>2012</strong>;121:e1-e9. PMID: 23095207<br />

579. Vozmediano C, Rivera F, Lopez-Gomez JM, Hernandez D. Risk fac<strong>to</strong>rs for renal failure in<br />

patients with lupus nephritis: data from the spanish registry of glomerulonephritis. Nephron<br />

Extra <strong>2012</strong>;2:269-77. PMID: 23139689<br />

580. Madureira Silva MV, Moscoso-Solorzano GT, Nishida SK, Mastroianni-Kirsztajn G. Serum<br />

Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis? Nephron Extra<br />

<strong>2012</strong>;2:169-76. PMID: 22811690<br />

581. Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, Song G ,et al. Cryopreserved dental<br />

pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative<br />

medicine. PLoS One <strong>2012</strong>;7:e51777. PMID: 23251621<br />

582. Vila L, Roglans N, Baena M, Barroso E, Alegret M, Merlos M ,et al. Metabolic alterations<br />

and increased liver mTOR expression precede the development of au<strong>to</strong>immune disease in a<br />

murine model of lupus erythema<strong>to</strong>sus. PLoS One <strong>2012</strong>;7:e51118. PMID: 23226562<br />

583. Arcipowski KM, Bishop GA. Roles of the kinase TAK1 in TRAF6-dependent signaling by<br />

CD40 and its oncogenic viral mimic, LMP1. PLoS One <strong>2012</strong>;7:e42478. PMID: 22860133<br />

584. Pau E, Cheung YH, Loh C, Lajoie G, Wither JE. TLR <strong>to</strong>lerance reduces IFN-alpha<br />

production despite plasmacy<strong>to</strong>id dendritic cell expansion and anti-nuclear antibodies in NZB<br />

bicongenic mice. PLoS One <strong>2012</strong>;7:e36761. PMID: 22574220<br />

585. Thiyagarajan D, Fismen S, Seredkina N, Jacobsen S, Elung-Jensen T, Kamper AL ,et al.<br />

Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin<br />

fragments and activation of Toll like recep<strong>to</strong>rs and the Clec4e. PLoS One <strong>2012</strong>;7:e34080. PMID:<br />

22479529<br />

586. Abdgawad M, Pettersson A, Gunnarsson L, Bengtsson AA, Geborek P, Nilsson L ,et al.<br />

<strong>Dec</strong>reased neutrophil apop<strong>to</strong>sis in quiescent ANCA-associated systemic vasculitis. PLoS One<br />

<strong>2012</strong>;7:e32439. PMID: 22403660


587. Prakash J, Brojen T, Rathore SS, Choudhury TA, Gupta T. The changing pattern of renal<br />

amyloidosis in Indian subcontinent: two decades of experience from a single center. Ren Fail<br />

<strong>2012</strong>;34:1212-6. PMID: 23009273

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!